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 ABSTRACT 
The existence of islet subpopulations according to size difference has been described since 
1869 when Dr. Paul Langerhans first discovered the islets in the pancreas. Unfortunately, little is 
known about the functional differences between islet subpopulations until recently. Small islets 
have been shown to secret more insulin than large islets per volume (islet equivalent; IE) and led to 
better transplantation outcome both in rodents and in humans. Insulin is produced and released 
from the β cells in islets through a cascading pathway from insulin gene transcription to proinsulin 
biosynthesis to insulin secretion. The central hypothesis of this dissertation is that small and large 
islets have different characteristics in insulin production and secretion that lead to different 
transplantation outcomes. More than ten thousands small (diameter ≤ 100µm) and large (diameter 
≥ 200µm) islets from healthy rats were investigated. First, the same percentage of β cells was 
identified in small and large islets, but small islets had higher density both in vitro and in situ. Next, 
a new regression model was established to better estimate the islet volume by cell number based on 
size (diameter), since an overestimation was seen when using conventional IE measurement to 
normalize islet volume. By applying this new normalization method, a superior glucose-stimulated 
proinsulin biosynthesis was identified in large islets. However, when normalized to cell number, 
insulin secretion was not different between small and large islets, unlike the results in literature 
when normalized to IE. While small and large islets showed no difference in total protein content 
per cell, large islets showed higher protein levels of prosinulin, NeuroD/Beta2 and MafA with a 
lower PDX-1 level under basal conditions suggesting that the different characteristics between 
small and large islets in the insulin production pathway may not correspond to measured insulin 
secretion. All the findings will not only elucidate new intricacies concerning islet biology research, 
but also will have significant implications to current islet transplantation research to optimize the 
success for curing type 1 diabetes. 
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Introduction
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 Solid understanding of the insulin-producing islet of Langerhans (islets) is a necessary 
base to optimize the success of curing diabetes. In the pancreas, islets vary in sizes. However, the 
roles of islet subpopulations remain unclear in current islet biology. The long-term goal of our 
research is to better understand islet biology to improve therapeutic strategies that can be 
applied to cure diabetes. Therefore, the objective of this dissertation was to characterize the 
differences between small and large islets in vitro and in situ, and to investigate the mechanisms 
of insulin production and secretion in these two populations by using an improved islet volume 
normalization method to compare the results. 
1.1. Islets of Langerhans 
 The human pancreas is both an exocrine and endocrine organ with an elongated shape. 
The head of the gland is closely attached to the distal two-thirds of the duodenum. The body of 
the pancreas is overlaid by the posterior wall of the stomach and the tail region ends near the 
splenic hilus. The main two functions of the pancreas are digestion and glucose homeostasis. The 
exocrine cells, which constitute approximately 98% of total mass of adult pancreas, release a 
mixture of digestive enzymes and bicarbonate into the duodenum to help with food digestion. 
The endocrine cells constitute 1~2% of total mass of pancreas that release several hormones into 
the portal vein. Cluster of endocrine cells form the islets of Langerhans, or islets, which were 
discovered by a German pathological anatomist Dr. Paul Langerhans (1847-1888) in 1869 
(Bloomfield, 1958).  
 In the pancreas, the islets lie scattered throughout the exocrine tissue in between the acini 
and ductal structures without a recognizable pattern. The distribution of islets varies widely from 
individual to individual. In the fetuses, islets contact duct closely. In neonates and adults, islets 
are more separated from the ducts. In adults, about 50% of the islets remain close to the duct 
(Watanabe, Yaegashi, Koizumi, Toyota, & Takahashi, 1999). In addition, the number of islets 
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seems to increase toward the tail region of the pancreas (K. Saito, Iwama, & Takahashi, 1978; 
Wittingen & Frey, 1974).  
 The islet is surrounded by a thin collagen capsule and glial sheet that separate islet cells 
from the exocrine tissue (Goldstein & Davis, 1968; Hughes et al., 2006; P. H. Smith, 1975). In 
the islet, besides the endocrine cells, small amount to connective tissue are present with blood 
vessels. The islet is pervaded by a dense capillaries network, which has a density five times 
higher than the exocrine capillary network (Ballian & Brunicardi, 2007; Zanone, Favaro, & 
Camussi, 2008). The capillary network plays a critical role for glucose homeostasis not only 
because of the high oxygen consumption of endocrine cells, but also because of the timely 
response to the changes in blood glucose levels that is required by endocrine cells to secrete 
hormones into the circulation. In addition, there are some other non-epithelial elements inside the 
islets such as macrophages (de Koning et al., 1998) and nerve fibers. Islets have sympathetic, 
parasympathetic and sensory innervations. The nerve fibers usually accompany the vascular 
system that release acetylcholine or noradrenaline to regulate insulin secretion. Insulin secretion, 
the most well-known function of the islet, is activated by the parasympathetic system but 
inhibited by the sympathetic system (Ahren, 1999).   
 Islets contain at least five different types of endocrine cells: Beta (β) or B cell, Alpha (α) 
or A cell, Delta (δ) or D cell, PP or F cell, and Epsilon cell. The β cell produces insulin, which 
lowers the blood glucose levels. The α cell produces glucagon, which plays role in 
hyperglycemic action. The δ cell produces somatostatin, an inhibitor of insulin and glucagon 
release. The PP cell produces pancreatic polypeptide, a regulator of pancreatic secreting 
activities including exocrine and endocrine. The epsilon cell produces ghrelin, which is thought 
to be important in growth hormone release, metabolic regulation and energy balance (Islam, 
2010). Among all types of endocrine cells, the insulin-producing β cells are the majority 
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(65%~80%) in the islet (el-Naggar, Elayat, Ardawi, & Tahir, 1993). In this dissertation, the 
mechanisms of insulin production and secretion in the β cells will be focused. 
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1.2. Mechanisms of Insulin Production and Secretion  
Insulin is produced through a cascading process in the β cell. First of all, the insulin gene is 
transcribed from DNA to preproinsulin mRNA through gene transcription. After transcription, 
the preproinsulin mRNA is translated into preproinsulin protein which exists the cell shortly. 
Then, the preproinsulin is processed into proinsulin, after the signal peptide is removed, and 
stored into granules. The proinsulin will be cleaved by specific enzymes (see below) into 
c-peptide and insulin. Finally, the mature insulin will be released from the cell by exocytosis to 
the blood stream (Figure 1). 
 Glucose stimulates β cells to produce insulin and regulates several aspects of 
insulin-producing process mentioned above. The elevation in blood glucose concentrations is the 
primary signal for insulin production which enhances insulin gene transcription, insulin protein 
synthesis and insulin release through the complex network of intracellular signaling pathways 
(Figure 1).  
1.2.1. Insulin Gene Transcription 
1.2.1.1. Preproinsulin mRNA 
 Preproinsulin mRNA is the product of insulin gene transcription that makes up 10~15% 
of the total mRNA in the β cell (Goodge & Hutton, 2000). Under basal conditions with a low 
plasma glucose concentration (<3 mM), large quantities of preproinsulin mRNA are present due 
to basal insulin gene transcription. However, at higher glucose concentrations, insulin 
transcription increases and more preproinsulin mRNA is produced. Efrat et al. suggested that 
high glucose (16.7 mM) stimulates insulin gene transcription about 3-fold after 10 minutes, and 
the transcriptional activity is maximal at 30 minutes, but markedly decreased thereafter (Efrat, 
Surana, & Fleischer, 1991). 
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Figure 1. Insulin production pathway. Glucose is the primary signal for insulin production that 
enhances insulin gene transcription, insulin protein synthesis and insulin secretion through the 
complex network of intracellular signaling pathways. 
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In addition, it is reported that incubating insulinoma cells and the isolated pancreatic islets in 
high glucose (16.7 mM) for only 15 minutes, results in a 2~5 fold elevation in preproinsulin 
mRNA levels within 60~90 minutes. The authors also observed that the glucose stimulatory 
effect is most obvious 30 minutes after the glucose exposure, but declines thereafter (Leibiger et 
al., 1998). Taken together, it is likely that the production of preproinsulin mRNA is affected by 
high glucose concentration within minutes. 
1.2.1.2. Glucose-responsive insulin gene transcription factors  
The transcription of insulin gene to preproinsulin mRNA is regulated by the interaction 
between the insulin promoter and the transcription factors. The human insulin gene is located on 
chromosome 11p15.5 in the β cell nucleus (Harper, Ullrich, & Saunders, 1981). The insulin 
promoter is a specific sequence of DNA nucleotides located near the transcription initiation site 
of the insulin gene that determines which one of the two strands of the double helix DNA will be 
transcribed. On the other hand, the transcription factors are the proteins that perform as gene 
switches at the promoter region to activate or repress the gene expression.  
Increased glucose levels activate upstream signals that are responsible for the activation of 
the transcription factors involved in insulin gene transcription. Three critical glucose-responsive 
transcription factors will be investigated in chapter 4, which are the homeodomain protein 
pancreas duodenum homeobox-1 (PDX-1), Beta-cell E-box trans-activator 2 (Beta2), and the 
basic region leucine zipper MafA (Figure 2).
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Figure 2. Summary of glucose control of insulin gene transcription. Glucose enters β cell via 
the glucose transporter 2 (Glut2) located on the plasma membrane and activates factors involved 
in insulin gene transcription through three main pathways. Pathway on the left: Glucose 
stimulates PDX-1 translocation from the cytoplasm to the nucleus and increases binding activity 
of PDX-1 to the insulin promoter (A3) through the pathway involving phosphatidylinosito 
3-kinase (PI3-K) activation. Pathway in the center: Glucose affects MafA gene expression at the 
mRNA level and activates binding activity of MafA to the insulin promoter (C1). Pathway on the 
right: Glucose also stimulates the binding activity of Beta2/NeuroD to the insulin promoter (E1) 
in β cells, which is dependent upon the phosphorylation of extracellular signal-regulated kinase 
(ERK) 1/2. 
 
  9
1.2.1.2.1. PDX-1 
 PDX-1 is essential for pancreas formation, β cell differentiation, and maintenance of 
mature β cell function. Mice lacking PDX-1, homozygotes (-/-), fail to develop a pancreas, 
known as pancreas agenesis (Jonsson, Carlsson, Edlund, & Edlund, 1994; Offield et al., 1996). A 
single nucleotide deletion in the human PDX-1 gene was reported in one patient with pancreas 
agenesis (Stoffers, Zinkin, Stanojevic, Clarke, & Habener, 1997). It has been suggested that 
PDX-1 may have the potency to drive beta-cell-like differentiation in non-beta-cells in adult 
murine liver (Imai et al., 2005) and intestinal epithelial cells (Yoshida et al., 2002). In addition, 
PDX-1 heterozygous (+/-) mutant mice have impaired islet insulin-producing function and 
develop diabetes with age (Ahlgren, Jonsson, Jonsson, Simu, & Edlund, 1998; Dutta, 
Bonner-Weir, Montminy, & Wright, 1998). A strong family history of maturity-onset diabetes of  
the young or MODY is associated with heterozygosity for a point mutation in the human PDX-1 
gene (Stoffers, Ferrer, Clarke, & Habener, 1997). Taken together, these data clearly suggested 
that PDX-1 plays a crucial role in pancreas formation, β cell differentiation, and maintenance of 
mature β cell function.   
The PDX-1 also plays an important role in linking glucose metabolism to the regulation of 
insulin gene transcription (Macfarlane et al., 2000). Increased glucose concentration enhances 
the potential of the PDX-1 activation domain and the binding of PDX-1 to the insulin gene 
promoter, a region upstream of the insulin gene termed A3 box, to activate the insulin gene 
transcription (MacFarlane, Read, Gilligan, Bujalska, & Docherty, 1994). Glucose also stimulates 
insulin gene promoter activity involving translocation of PDX-1. In MIN6, a cultured β cell line, 
increasing glucose levels stimulates the shift in PDX-1 from the nuclear periphery and 
membrane region to the nucleoplasm and increases the activity of insulin promoter and insulin 
gene transcription (Rafiq, da Silva Xavier, Hooper, & Rutter, 2000; Rafiq, Kennedy, & Rutter, 
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1998). In addition, it is suggested that glucose activates PDX-1 function and stimulates insulin 
gene promoter activity via intracellular singling pathways. Glucose entry into the β cell is 
accomplished via the glucose transporter 2 (Glut2) located on the plasma membrane. After 
entering the β cell through Glut2, glucose activates the phosphorylation of phosphatidylinositol 
3-kinase (PI3-K) to activate PDX-1 function (Elrick & Docherty, 2001; Rafiq et al., 2000). These 
data suggested that glucose stimulates PDX-1 translocation and increases PDX-1 DNA binding 
activity through the pathway involving PI3-K activation (Figure 2). 
1.2.1.2.2. NeuroD/Beta2 
Beta-cell E-box trans-activator 2 (Beta2) belongs to the basic helix-loop-helix (bHLH) 
proteins, also known as NeuroD (Neurogenic Differentiation Factor). The expression pattern of 
NeuroD/Beta2 suggests a role in endocrine pancreas development. Abnormal pancreatic islet 
morphogenesis is found in Beta2-deficient mice (Naya et al., 1997). Mice homozygous for the 
NeuroD/Beta2 gene deletion develop diabetes and die 3~5 days after birth due in part to 
inadequate insulin gene expression (Naya et al., 1997). In addition, the mutation in 
NeuroD/Beta2 leads to the development of type 2 diabetes in humans due to deficit or inactive 
binding of NeuroD/Beta2 transcription factor to a insulin promoter (Malecki et al., 1999).  
NeuroD/Beta2 is an important transcriptional activator in pancreatic β cells for 
glucose-stimulated insulin gene transcription. NeuroD/Beta2 binds to the E1 box of the insulin 
gene promoter to transcribe the insulin gene (Naya, Stellrecht, & Tsai, 1995). Glucose stimulates 
the binding activity of NeuroD/Beta2 to the insulin promoter (E1 box) in β cell. This reaction is 
dependent upon extracellular signal-regulated kinase (ERK) 1/2 which regulates the gene 
transcription (Khoo et al., 2003). Glucose activates β cell ERK1/2 phosphorylation, and 
phosphorylated ERK1/2 further enhance Beta2 and E47 (a ubiquitous bHLH protein) 
heterodimerization and binding to E-box sites (Lawrence, McGlynn, Park, & Cobb, 2005) 
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(Figure 2). Taken together, these results suggested that NeuroD/Beta2 plays an important role in 
pancreas development as well as in regulating insulin gene transcription. 
1.2.1.2.3. MafA 
MafA belongs to the Maf (v-maf musculoaponeurotic fibrosarcoma oncogene homolog 
(avian)) family of transcription factors. It is a principal factor required for the pancreatic β cell 
formation and function. MafA is expressed specifically in the β cells of islets (Olbrot, Rud, Moss, 
& Sharma, 2002), and its expression is the first detected at the beginning of the β cell 
development (Matsuoka et al., 2004). MafA-deficient (-/-) mice displayed age-dependent 
pancreatic islet abnormalities, and diminished expression of PDX-1, NeuroD/Beta2, and Glut2 
(Zhang et al., 2005). In addition, MafA is suggested as a master regulator of genes implicated in 
insulin biosynthesis and secretion (Wang, Brun, Kataoka, Sharma, & Wollheim, 2007). These 
results strengthen the crucial role of MafA for β cell formation and function. 
MafA functions as a glucose-regulated transcriptional activator that binds to the C1 site of 
insulin promoter for insulin gene expression (Figure 2). In MafA-deficient (-/-) mice, 
glucose-stimulated insulin secretion is severely impaired (Zhang et al., 2005). The mechanism by 
which MafA is activated by glucose is different from PDX-1 and NeuroD/Beta2. Glucose 
induces post-translational modification of PDX-1 and NeuroD/Beta2, but glucose activates 
MafA through increasing MafA gene transcription. The expression of MafA mRNA and protein 
in MIN6 β cell line is dependent on glucose concentration, which is correlated with preproinsulin 
mRNA level. MafA protein is detected in the nucleus of MIN6 β cells when stimulated by 
glucose (Kataoka et al., 2002). Incubating isolated rat islets in 16.7mM glucose for 24 hours 
increases MafA mRNA level. Also, MafA protein expression is undetectable under basal 
conditions (2.8mM glucose), but readily detected at a high concentration of glucose (16.7mM) 
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(Hagman, Hays, Parazzoli, & Poitout, 2005). Therefore, these data suggest that glucose activates 
MafA expression to enhance insulin gene transcription. 
1.2.2. Insulin Protein Biosynthesis 
After transcription, the preproinsulin mRNA moves from the nucleus into the cytoplasm for 
the insulin biosynthesis through a cascading process as followed. First, the mRNA binds to the 
free ribosome, a cell organelle that contains the enzymes and rRNAs (ribosomal RNA) required 
for the translation, to assemble polypeptide chain (protein) (Figure 3A). The first sequence of 
synthesized peptide, known as signal sequence or signal peptide, on the surface of ribosome then 
acts as a recognition signal to direct the ribosome to bind to the granular endoplasmic reticulum 
(ER) to continue the protein assembly (Figure 3B). The growing preproinsulin polypeptide is fed 
through a protein complex in the granular ER membrane into the lumen of the reticulum. After 
completion of polypeptide synthesis, the completed preproinsulin protein is released from the 
ribosome (Figure 3C). Within the lumen of the granular ER, the “pre-portion” of the 
preproinsulin (such as the signal peptide) is removed enzymatically forming the proinsulin. 
Following the modification, portions of the ER membrane develop vesicles that contain the 
newly synthesized proinsulin protein (Figure 3D). These proinsulin vesicles are transported to 
the Golgi apparatus and fuse with the Golgi membranes (Figure 3E). The Golgi apparatus is a 
cell organelle that concentrates, modifies and sorts the proteins arriving from the ER. In the 
Golgi apparatus of β cells, the proinsulin proteins are packaged into immature granules that bud 
off the surface of the Golgi membrane (Figure 3E) and are further converted to insulin and 
C-peptide (Figure 3F) by the processing enzymes (Orci et al., 1987). Proprotein convertase 
1(PC1), proprotein convertase 2 (PC2) and carboxypeptidase E (CPE) are the enzymes that are 
involved in proinsulin cleavage resulting in insulin and c-peptide production in the β cell (Figure 
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Figure 3. The process of insulin protein biosynthesis. First, the preproinsulin mRNA binds to 
the free ribosome, to assemble polypeptide chain. The first sequence of synthesized peptide acts 
as a recognition signal to direct the ribosome to bind to the granular endoplasmic reticulum (ER) 
to continue the protein assembly. The growing preproinsulin polypeptide is fed through a protein 
complex in the granular ER membrane into the lumen of the reticulum. After protein assembly, 
the completed preproinsulin protein is released from the ribosome. Within the lumen of the 
granular ER, the “pre-portion” of the preproinsulin is removed enzymatically forming the 
proinsulin. Following the modification, portions of the ER membrane develop vesicles that 
contain the newly synthesized proinsulin protein. These proinsulin vesicles are transported to the 
Golgi apparatus and fuse with the Golgi membranes. In the Golgi apparatus of β cells, the 
proinsulin proteins are packaged into immature granules that bud off the surface of the Golgi 
membrane and are further converted to insulin and C-peptide by the processing enzymes. The 
granules then become mature intracellular granules in which the insulin crystals are composed. 
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3F). The granules then become mature intracellular granules in which the insulin crystals are 
composed. Since the preproinsulin’s life time in the ER is very short, its level is quite difficult to 
detect. Proinsulin, however, is more stable and is easier to detect than the preproinsulin. 
Therefore, proinsulin is usually referred to as the product of preproinsulin mRNA translation, 
even though the preproinsulin is the actual translation product in the whole process of insulin 
biosynthesis. For simplicity, in this thesis, we will refer to the preproinsulin mRNA translation 
product as proinsulin. 
Glucose is the most physiologically relevant factor that regulates the insulin protein 
biosynthesis at the translational level. Glucose stimulates the recruitment of preproinsulin mRNA 
from an inert cytosolic pool to the rough ER, the site of preproinsulin synthesis (Itoh & Okamoto, 
1980; Welsh, Scherberg, Gilmore, & Steiner, 1986). After one hour of incubation at high glucose 
(16.7 mM), proinsulin level in the rat islets increases up to 6-fold (Wicksteed, Alarcon, Briaud, 
Lingohr, & Rhodes, 2003) and even more than 15-fold shown by another study (Guest, Rhodes, 
& Hutton, 1989). In addition, proinsulin synthesis is dose-dependent under glucose stimulation. 
In purified pancreatic β cells, proinsulin synthesis increased 25-fold when glucose was increased 
from 1 to 10 mM for one hour (Schuit, In't Veld, & Pipeleers, 1988). These results further 
strengthen the role of glucose in insulin protein biosynthesis. 
1.2.3. Insulin Granules Secretion 
1.2.3.1. Directing insulin granules to the plasma membrane 
After synthesis, the mature insulin granules (or vesicles) in the cytoplasm are secreted into 
the extracellular space. In order to release insulin, the insulin granules (or vesicles) must be 
translocated from the cytoplasm to the plasma membrane where they fuse with the membrane. 
SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) is an important 
group of proteins that direct the insulin granules to the plasma membrane. The linking of 
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target-SNARE (t-SNARE) plasma membrane proteins, syntaxin and synaptosomal-associated 
protein 25 (SNAP-25), with the vesicle-SNARE (v-SNARE) protein, vesicle-associated protein 2 
(VAMP-2) or synaptobrevin-2, is critical for docking insulin granules with the plasma membrane 
and the L-type voltage dependent Ca2+-channel (L-VDCC) on the membrane. After fusing with 
the plasma membrane, insulin granules are released in response to the products of glucose 
metabolism. 
1.2.3.2. Glucose-induced insulin release  
The mechanism for how glucose triggers insulin release has been well established. 
ATP-sensitive K+ (KATP) channel-dependent pathway is one of the glucose-induced insulin 
release pathways that trigger insulin release (Figure 4). Intracellular glucose is metabolized to 
generate adenosine triphosphate (ATP), a nucleotide that plays a role as the source of energy for 
intracellular energy transfer. The KATP channel on the cell membrane will be closed by an 
increase in ATP that depolarizes the membrane and enhances membrane excitability. The 
membrane depolarization then opens the L-type voltage dependent Ca2+ -channels (L-VDCC) in 
pancreatic β cell, and increases the influx of calcium. The elevated intracellular Ca2+ 
concentration causes exocytosis of the insulin granules located close to the plasma membrane 
and the Ca2+-channels (Bratanova-Tochkova et al., 2002). After granules have undergone 
exocytosis, the empty vesicle membrane is rapidly dissociated from the plasma membrane and 
recaptured by endocytosis, a process with opposite function as exocytosis, for the recycling 
purpose (Sudhof, 1995). In addition, glucose stimulates the discharges of the docked insulin 
granule and dissociates the docking proteins SNARE complex between the vesicle and plasma 
membrane (Daniel, Noda, Straub, & Sharp, 1999). Taken together, glucose plays a crucial role in 
insulin secretion through KATP channel-dependent pathway.   
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Figure 4. Glucose-induced insulin release through the ATP-sensitive K+ (KATP) 
channel-dependent pathway. Intracellular glucose is metabolized to generate ATP. The KATP 
channel on the cell membrane is closed by an increase in ATP that depolarizes the membrane 
and enhances membrane excitability. The membrane depolarization then opens the L-type 
voltage dependent Ca2+ -channels (L-VDCC) in pancreatic β cell, and increases the influx of 
calcium. Elevated intracellular Ca2+ concentration causes exocytosis of the insulin granules 
located close to the plasma membrane and the Ca2+-channels. (SG: Secretory Granules)  
 
Figure 5. Granule pools and biphasic insulin secretion. (A) Schematic of glucose-induced 
insulin secretion. (B) β cell contains two pools of secretory granules. A limited pool of granules 
(<5%) are immediately available for release, the readily releasable pool (RRP) of granules 
(green). Most granules (>95%) initially belong to a reserve pool (red) and must undergo a series 
of preparatory reactions in order to gain release competence (mobilization). The release of RRP 
granules accounts for first-phase secretion and its end marks the depletion of this pool. The 
subsequent supply of new granules for release by mobilization accounts for second-phase insulin 
secretion. 
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1.2.3.3. Biphasic insulin secretion 
Insulin secretion in response to increased glucose concentrations exhibits a biphasic pattern 
consisting of a rapidly initiated and transient first phase (lasting 5~10 minutes) followed by 
slowly developing and sustained second phase (Figure 5 ). This characteristic biphasic pattern 
has been identified more than 30 years ago (Curry, Bennett, & Grodsky, 1968). It is observed 
both in vitro (islets) and in vivo (including human) (Cerasi, 1975; Lacy, Walker, & Fink, 1972; 
Luzi & DeFronzo, 1989).  
Only a small fraction of the β cell insulin content is released in response to a single glucose 
stimulus. In the first phase, less than 5% of the insulin granules in the β cell are available in the 
readily releasable pool for membrane fusion, and the granule secretion rate has been reported to 
amount to 0.14% of the total insulin content in the β cell per minute. However, more than 95% of 
insulin granules belong to a reserve pool. In the second phase, the granule secretion rate is only 
0.05% of the total insulin content per minute (Rorsman & Renstrom, 2003). Given that every β 
cell contains about 13,000 granules (Dean, 1973), these release rates correspond to 
approximately 18 and 7 granules per minute per beta cell in the first and second phases, 
respectively. In addition, the first phase insulin release from the readily releasable pool is 
regulated by glucose stimulation through the KATP channel-dependent pathway, with increasing 
Ca2+ causing insulin granule release or exocytosis. While the readily releasable pool is associated 
with the first phase of glucose-induced insulin release, glucose also plays a role in the second 
phase of glucose-induced insulin release that involves the mobilization and priming process of 
insulin granules from reserve pools to the readily releasable pool to gain the competence for the 
sustained second phase release (Bratanova-Tochkova et al., 2002).
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1.3. Small and large islets 
1.3.1. Size-frequency distribution 
 The existence of islet subpopulations according to size difference has been recognized 
since the Dr. Paul Langerhans discovered the islets in the pancreas in 1869 (Bloomfield, 1958). 
Islets vary in size and range from a very small cell cluster with only a few cells to large 
aggregates of many thousands of cells. The size and volume of islets is associated with 
significant morphological difference distinguishing islet subpopulations in mammalian pancreas. 
 The size distribution of islets was continuous from 20μm to more than 400μm in diameter 
and skewed with only one peak in the distribution curve (Figure 6). In 1959, it was reported that 
smaller islets are more numerous in human pancreas (Hellman, 1959a). In 1986, a Japanese 
group investigated the radial size and number of human islets by a thin serial pancreas section 
technique combined with immunostaining insulin and glucagon. They suggested that the 
majority of islets were the small islets, but the small islets accounted for only a very small 
percentage of the total islet volume in the pancreas (Kaihoh, Masuda, Sasano, & Takahashi, 
1986). In addition, with advances in the methods of islet isolation and digital image analysis, 
researchers were able to confirm these findings (Buchwald et al., 2009; Friberg et al., 2011; 
Girman, Berkova, Dobolilova, & Saudek, 2008). For example, by dividing islets population into 
two groups by size which are small (diameter below 125μm) and large (diameter above 150μm), 
the amount of small islets in the pancreas is near 3-fold greater than large islets. However, in 
terms of the proportion of the total volume, large islets account for approximately 73% of total 
islet volume and small islets comprise the remaining 27% (MacGregor et al., 2006). In addition, 
more small islets were identified in the upper duodenal region of pancreas, while more large 
islets were seen in the splenic region (A. A. Elayat, M. M. el-Naggar, & M. Tahir, 1995). 
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1.3.2. Size-related insulin secretion and transplantation outcome 
 Islet size is a major determinant in islet insulin secretion. While one small islet produces less 
insulin than one large islet (T. Aizawa et al., 2001), in terms of islet tissue volume, however, the small 
islets have been shown superior in insulin secretion as compared to the large islets per volume (Fujita et 
al., 2011; Hayek & Woodside, 1979; H.-H. Huang, L. Novikova, S. Williams, I. Smirnova, & L. 
Stehno-Bittel, 2011; Lehmann et al., 2007; MacGregor et al., 2006; Su et al., 2010; Williams et al., 2010). 
In 2006, our group published a paper describing that the small rat islets (diameter <125μm) are 
superior to large islets (diameter >150μm) in insulin secretion per volume when using the islet 
equivalent (IE) to normalize. After separating small islets from large islets through sedimentation, 
we identified that the small islets released three times and four times respectively more insulin 
under basal conditions (3mM) and high concentration (30mM) than did large islets (MacGregor 
et al., 2006). Subsequent experiments found similar results in mouse and human islets (Lehmann 
et al., 2007; Su et al., 2010). Small human islets produce almost twice the amount of insulin 
compared to same IE of large islets in the basal state (2.8mM glucose) and during high 
simulation (20mM) glucose perifusion experiments (Lehmann et al., 2007). In addition, 
transplanting small rat islets into type 1 diabetic animal model surprisingly led to better blood 
glucose control 60 days after transplantation in comparison to the same volume of large islets 
(Figure 7)(MacGregor et al., 2006). In human, the type 1 diabetic patients who received 
relatively higher amount of small islets were shown having better transplantation outcome 
(Lehmann et al., 2007). Taken together, our central hypothesis is that small and large islets 
may have different mechanisms in insulin production and secretion.  
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Figure 6. Size and number dispersion of isolated rat islets. The figure illustrates a typical rat 
islet dispersion on the basis of islet size. The distribution curve skewed with only one peak in the 
small islet (75~100μm). (MacGregor, R.R., et al., 2006) 
 
 
Figure 7. 60 days follow-up for small and large islet transplantation in rat model of type 1 
diabetes. When small islets were transplanted (red lines), glucose levels of rats were normal in 
all but 1 animal after transplantation. Transplants using large islets (black lines) were all 
unsuccessful. (MacGregor, R.R., et al., 2006) 
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1.4. Research question 
The long-term goal of our research is to better understand islet biology to improve islet 
transplantation strategies. Since the small islet secretes more insulin per volume (IE) of tissue 
than the large islet, we believe there must be some characteristics different in the insulin 
producing capacity between small and large islets. However, the differences in the mechanisms 
of insulin production between small and large islet subpopulations are unclear. Therefore, the 
objective of this dissertation was to investigate the mechanisms of insulin production and 
secretion in small and large rat islets. 
In chapter 2, “Low insulin content of large islet population is present in situ and in isolated 
islets”, we determined whether the differences of insulin producing capacity in isolated small and 
large islets are solely a result of the ability to withstand the isolation procedure, or whether these 
characteristic differences between islet subpopulations exit inherently in the pancreas (in situ). 
   In Chapter 3, “Total cell number- a superior model for volume quantification of isolated 
islets”, we created and tested a new method to more accurately quantify the amount of islet tissue 
being used in the experiments, and found that the IE normalization method actually affected 
some of our initial results. 
 In Chapter 4, “The insulin biosynthesis pathway in small and large islets does not 
correspond to insulin secretion”, by applying the more accurate normalization method described 
in Chapter 3, we compared the mechanisms of insulin production and secretion in early response 
to glucose stimulation in small and large islets at cellular levels. 
In Chapter 5, we summarized all the findings from chapters 2 through chapter 4. We also 
discussed the implications of this dissertation to the islet biology and transplantation fields. In 
addition, the future directions were suggested in this chapter.   
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Chapter 2                    
Low Insulin Content of Large Islet Population 
is Present in Situ and in Isolated Islet
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2.1. Abstract 
 The existence of morphologically distinct populations of islets in the pancreas was 
described over 60 years ago. Unfortunately, little attention has been paid to possible functional 
differences between islet subpopulations until recently. We demonstrated that one population, 
the small islets, were superior to large islets in a number of functional aspects. However, that 
work did not determine whether these differences were inherent, or whether they arose because 
of the challenge of isolation procedures. Nor, were there data to explain the differences in insulin 
secretion. We utilized immunohistochemistry, immunofluorescence, ELISA, and transmission 
electron microscopy to compare the unique characteristics found in isolated rat islet populations 
in situ and after isolation. Insulin secretion of small isolated islets was significantly higher 
compared to large islets, which correlated with higher insulin content/area in small islets (in situ), 
a higher density of insulin secretory granules, and greater insulin content/volume in isolated 
islets. Specifically, the core β-cells of the large islets contained less insulin/cell with a lower 
insulin granule density than peripheral β-cells. When insulin secretion was normalized for total 
insulin content, large and small islets released the same percentage of total insulin. Small islets 
had a higher density of cells/area than large islets in vitro and in situ. The data provide a possible 
explanation for the inferior insulin secretion from large islets as they have a lower total cell 
density and the β-cells of the core contain less insulin/cell.
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2.2. Introduction 
Morphometrical analysis, first reported in 1947, showed differences in size distribution, 
number and volume of islets from several species (T Aizawa et al., 2001; Bonnevie-Nielsen & 
Skovgaard, 1984; A. Elayat, M. el-Naggar, & M. Tahir, 1995; Furuzawa, Ohmori, & Watanabe, 
1992; Haist & Pugh, 1947; Jörns, Barklage, & Grube, 1988; White, Hughes, Contractor, & 
London, 1999) including human (Aguayo-Mazzucator, Sanchez-Soto, Godinez-Puig, 
Gutie'rrez-Ospina, & Hiriart, 2006; Baetens, Malaisse, Perrelet, & Orci, 1979; Bosco et al., 2010; 
Cabrera et al., 2006; K Saito, Takahashi, Yaginuma, & Iwama, 1978). In spite of morphological 
analysis showing distinct populations of islets, most researchers and clinicians still consider all 
islets to be functionally equivalent. 
It is surprising that many of the details about the function of islets are still unknown 
(Cabrera et al., 2006; Tasaka, Matsumoto, Inoue, & Hirata, 1989). In 2001 an important paper 
examined the functional differences between islets that related to their size (T Aizawa et al., 
2001). The authors showed a variety of functionally different islet characteristics, including the 
fact that 60% of the islets responded to glucose challenge with a dose-dependent insulin release, 
versus 32% of islets that had an all-or-none response. Other structural variations based on islet 
size were published recently (Bosco et al., 2010). 
Our laboratory reported that isolated small islets from rats were superior to large islets in 
function and in transplantation outcomes, especially when measuring insulin secretion 
(MacGregor et al., 2006). Subsequent experiments by other laboratories confirmed similar results 
in human and mouse islets (Lehmann et al., 2007; Su et al., 2010). To further characterize these 
differences, we determined that large islets contained a significant diffusion barrier that 
hampered viability of the islets in culture (Williams et al., 2010). Surprisingly, elimination of the 
diffusion barrier in large rat islets did not restore insulin secretion to the same rate as intact small 
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islets, suggesting that there were inherent cellular differences between large and small islets 
(Williams et al., 2010) that might explain the inferior insulin secretion by the cells within the 
large islets.  
The behavior of islets in culture has important implications for islet transplantation. Yet a 
more important question lingers, are these differences in islet function solely a result of the 
ability of islets of different sizes to withstand the isolation procedure, or do these functional 
differences exist in vivo? The experiments described in this paper begin to elucidate the 
morphological and functional differences in rat islet subpopulations, and to determine whether 
these differences exist prior to isolation.
 
  26
2.3. Methods 
Rat islet isolation 
Twenty-six adult, male Sprague Dawley rats (ages 7-10 weeks) were housed on a 12 hours 
light/dark cycle with free access to standard laboratory chow and water. All animals received 
care in compliance with the Principles of Laboratory Animal Care formulated by the National 
Society for Medical Research and the Guide for the Care and Use of Laboratory Animals 
published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996). 
Islet isolation methods followed our published procedures described in detail.(MacGregor et 
al., 2006; Williams et al., 2010; S. Williams et al., 2009). Briefly, rats were anesthetized by 
intraperitoneal injection of a mixture of ketamine and xylazine. After the peritoneal cavity was 
exposed, the pancreatic main duct to the intestine was clamped and the pancreas cannulated in 
situ via the common bile duct. The pancreas was distended with collagenase and removed. Islets 
were gently tumbled, washed, and passed through a sterile 30 mesh stainless steel screen and 
centrifuged. The pellet was mixed with Histopaque, centrifuged, and the islets floating on the 
gradient were collected and sedimented. Islets were passed through a sterile 40µm mesh cell 
strainer with Hank’s Buffered Salt Solution (HBSS). After this cleaning process, islets were 
placed into CMRL 1066 medium containing 2 mM glutamine, 10% fetal bovine serum (FBS) 
and 1% antibiotic/ antimycotic solution and put into a 37ºC culture chamber containing 5% CO2. 
Prior to experiments, the islet culture media was changed to L15 containing 10% FBS and 
5mM HEPES, and islets were transferred into 37ºC culture chamber without CO2. Isolated islets 
were separated by size manually or by using the COPAS biosorter (Williams et al., 2010). The 
diameter of every islet was recorded for calculating total islets volume using light microscopy. 
Islet Equivalents (IE) were calculated by taking duplicate samples of each batch of islets 
(comprising < 2% of the islet fraction). Individual islets were counted and their diameters 
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measured. For irregularly shaped islets, two to four diameter measurements were taken at 
different locations on the islet and averaged. Islet volumes were calculated and converted to IE 
for the sample and the entire islet fraction.  
Cell dispersion 
For single cell assays, intact isolated islets from 8 rats were exposed to calcium-magnesium 
free HBSS 14.8 mM HEPES with papain (5 U/ml final concentration) using our published 
protocol (S. Williams et al., 2009). After incubation on a rotator at 37°C for 30 min, the islets 
were pipetted, dispersing them into single cells. The cells were transferred to CMRL 1066 as the 
final culture medium. When necessary, islets or dispersed β-cells were identified with dithizone 
labeling following published procedures (Mythili, Patra, & Gunasekaran, 2003; S. Williams et al., 
2009). 
Tissue preparation for immunostaining 
Seven rats were anesthetized and transcardially perfused with 80-100 ml of physiological 
saline, followed by 250 ml of a fixative solution containing 4% paraformaldehyde in 0.1 M 
phosphate buffered saline (PBS, pH 7.4) within 9 min of extermination. The pancreas was 
removed and dissected into three parts (head, middle and tail). Only the tail section was used for 
the analysis in this study. 
Pancreatic samples and isolated islets were fixed in 10% normal buffered formalin in PBS, 
pH 7.4 for three days at 4°C. Paraffin embedded tissue sections were cut (7-10 µm thickness), 
mounted on Superfrost/Plus microscope slides (Fisher Scientific, # 12-550-15) and dried at 40°C 
overnight and stored at 4°C until processing. The paraffin embedded sections were 
deparaffinized/rehydrated in xylene followed by ethanol and PBS serial rehydration. Antigen 
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retrieval was completed in 0.01M citrate buffer, pH 6.2, with 0.002M EDTA for 30 min using a 
steamer. Slides were permeabilized in 1.0 % Triton X-100 in 0.1 M PBS for 30 min. 
Immunofluorescence staining 
Sections from 3 rats (> 75 islets) were blocked in 10% normal donkey serum (NDS), 1.0% 
bovine serum albumin (BSA), and 0.03% Triton X-100 diluted in 0.1 M PBS for 30 min. 
Incubation with the primary antibody mix was performed at 4°C overnight in a wet chamber 
followed by incubation with the mix of fluorophore conjugated secondary antibodies at room 
temperature for 2 hr in a wet chamber protected from light. Both primary and secondary 
antibodies were diluted in 1% NDS, 1% BSA, and 0.03% Triton X-100. Slides were mounted 
with anti-fading agents. In some cases, 4',6-diamidino-2-phenylindole (DAPI, 0.5 µg/ml 
Molecular Probes, # D1306) staining was performed to reveal the nuclei for 5 min at room 
temperature after the secondary antibody exposure. 
Primary antibodies used were the following: anti-insulin (1:100, Abcam, # ab7842; 1:100, 
Santa Cruz Biotechnology, # sc-9168),), anti-glucagon (1:200, Abcam, # ab10988), and 
anti-somatostatin (1:200, Abcam, # ab53165). Corresponding secondary antibodies were 
conjugated with Cy2 (1:200, Jackson ImmunoResearch Laboratories Inc., # 706-225-148), Alexa 
647 (1:400, Molecular Probes, # A31573), Alexa 555 (1:400, Molecular Probes, # A31570), or 
DyLight 488 (1:400, Jackson ImmunoResearch Laboratories Inc., # 706-485-148).  
Images were obtained on an Olympus Fluoview 300 confocal microscope or using a Nikon 
C1Si or a C1Plus confocal microscope. Images were acquired using 10X - 100X objectives 
(depending on the experiment), and analyzed using FlouView or Ps Adobe Photoshop CZ4 
software. 
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Immunohistochemistry 
Insulin immunohistochemistry (IHC) was completed on pancreatic sections from four rats 
using anti-insulin (1:100, Santa Cruz Biotechnology, Inc., # sc-9168) and Vectastain Elite ABC 
kit (Vector Laboratories, #PK-6101) in combination with 3,3’-diaminobenzidine Peroxidase 
Substrate kit (Vector Laboratories, # SK-4100) as per manufacturer instructions. On occasions, 
3-amino-9-ethyl-carbazole (AEC) was used. After staining, slides were dehydrated in xylene and 
placed on coverslips in Permount mounting medium (Fisher Scientific, #S15-100). The 
specificity of insulin immunoreactivity was confirmed by omitting the primary antibodies from 
some sections. Images were collected on a Nikon Eclipse 80i microscope and analyzed with Ps 
Adobe Photoshop CZ4 extended software, by determining the average pixel value of staining per 
cell or per islet. Background staining was subtracted from each value. 
Cell composition  
To determine the cell composition, the relative proportion of immuno-labeled endocrine (α, 
β, and δ) cells in pancreatic sections from 3 rats or preparations of single dispersed cells [200 
islets from 6 rats dissociated into single cells with 6 aliquots of single cells from each group 
(small or large)] were evaluated by counting the number of individual types of cell and dividing 
by the total sum of endocrine cells per islet. In addition, DAPI was used to count the total cell 
number in the preparation.  
Islet perifusion 
Small and large islets (1400 islets) from six rats were preincubated for 90 minutes in RPMI 
1640 medium containing 10% FBS and 3mM glucose at a 37°C with 5% CO2. After 
preincubation, the islets were incubated in the glucose perifusion system individually with a 
constant flow rate (500µl/min) at 37°C for 90 minutes including: 30 minutes of basal condition 
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(3mM glucose) following by 30 minutes of high glucose concentration (20mM) and 30 minutes 
of basal condition (3mM glucose). During the perifusion, samples of medium with released 
insulin were collected from the output fraction every 3 minutes starting with the last 10 minutes 
of the first low glucose exposure. Samples were frozen at -80°C. At the end of the perifusion, the 
islets were harvested and frozen at -80°C. The total protein in the islets was extracted by acid 
ethanol (0.18M HCl in 95% ethanol). The released insulin and the total intracellular insulin 
amounts of large and small islets were determined by the ELISA (ALPCO, Salem, NH) as we 
have published previously (MacGregor et al., 2006; Williams et al., 2010; S. Williams et al., 
2009). 
Transmission electron microscopy 
 Islets from 5 rats were treated with 10 nM AuNP-DNA-Cy for 24 hours, washed twice 
with PBS, and then transferred to fresh media containing no AuNPs for an additional 72 hours. 
Islets were pelleted and immersed in 2% paraformaldehyde/2.5% glutaraldehyde in 0.1M sodium 
cacodylate buffer (SCB). The islets were then rinsed with 0.1M SCB and placed in secondary 
fixative containing 2% osmium tetraoxide in 0.1M SCB. Next, islets were rinsed with distilled 
water and stained with 3% uranyl acetate. The fixed islet samples were rinsed with distilled 
water before undergoing a graded ethanol dehydration series. Propylene oxide was used as a 
transitional solvent and tissues were embedded in Embed 812 resin. Samples were placed in a 
60°C oven to cure. The blocks were sectioned at the islet equatorial region using a Leica UCT 
ultramicrotome (80nm thin) and then mounted on grids for imaging. Images were captured from 
random sections using a J.E.O.L. JEM-1400 electron microscope. Insulin granules 
(halo-containing granules) were counted per μm2 in β-cells from small islets (105 cells from 46 
islets) and in the periphery (outer 3 layers) or core of large islets (155 cells from 60 islets) using 
standard procedures (Pisania, Weir et al., 2010; Stefan, Meda, Neufeld, & Orci, 1987). Total cell 
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density was analyzed by counting cells within a 25X25 μm region of interest in the core of each 
islet using published protocols at 3,800X magnification (Obermuller et al., 2010). This method 
tends to overestimate the absolute cells/area, but the objective of the calculations was to compare 
one population of islets to another, rather than obtain an absolute value, and the approach was 
applied uniformly to islets of both populations. Our published protocol was utilized to determine 
mitochondrial quality from final magnifications of 10,800X (Y. M. Searls, I. V. Smirnova, B. R. 
Fegley, & L. Stehno-Bittel, 2004). 
Statistics 
 Over 2225 islets from 26 rats were analyzed for this study. The experimental design 
included comparing large and small islets from healthy animals, thus each animal provided islets 
for both groups. The exact number of islets/experiment is shown in the methods section. 
Two-Way ANOVA with Fisher Least Significant Difference (LSD) test or a Kruskal-Wallis 
ANOVA on Ranks was used to compare multiple groups. For the single cell assays 
(immunostaining and TEM experiments) nested ANOVA was used. All figures and tables 
include means ± SE. P value < 0.05, was considered statistically significant. 
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2.3. Results 
Insulin secretion 
 Perifusion experiments illustrated that under basal conditions, and at each time point of 
the biphasic response, the small islets released more insulin per volume (islet equivalent; IE) 
than large islets. Figure 8 shows the results of the enzyme linked immunosorbent assay (ELISA) 
from approximately 1,400 islets from 6 rats. While similar results have been published 
previously with human islets (Lehmann et al., 2007), the rationale given for the difference in 
insulin secretion between large and small islets has been attributed to core cell death in the large 
isolated islets (MacGregor et al., 2006). Our previous publication indicated that such an 
explanation was insufficient to account for the dramatic differences in insulin secretion from 
large islets (Williams et al., 2010). Thus, we designed a series of experiments to determine 
whether there existed inherent differences in large and small islets prior to isolation that could 
account for the different insulin secretion rates.  
Islet cell composition 
 The first hypothesis to be tested was that small islets contained a higher percentage of 
β-cells than large islets and this accounted for the higher insulin secretion. Using 
immunofluorescently-stained serial sections of the pancreas, the islet cell composition was 
analyzed (Figure 9A & B). In order to critically classify the islet as large or small, serial sections 
of 10 μm were obtained and only sections with the greatest islet diameter were analyzed. 
Approximately 60% of the endocrine cells were composed of β-cells in large and small islets in 
situ ( 
Table 1). 
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Figure 8. Small isolated islets secrete more insulin per volume. Isolated islets were separated 
into large and small populations and exposed to low and high glucose (indicated at top of graph).  
At each time point more insulin was released by the small islets than the large (p < 0.001).  
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Figure 9. Cellular composition does not differ with islet population. Islets were 
immuno-fluorescently labeled for β-cells (insulin = green), α-cells (glucagon = red), and δ-cells 
(somatostatin = blue). Small (A) and large (B) islets labeled within pancreatic sections (in situ) 
show same general cell composition. Small (C) and large (D) islets after isolation also have the 
same general composition. Loss of peripheral α-and δ-cells was noted in the isolated islets (C & 
D) compared to in situ (A & B). (Scale bar = 50µm for all images) 
 
A. B. 
C. D.
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Table 1. Cell composition in small and large islets in situ and in vitro. 
 Small Islets  
(% of endocrine cells) 
Large Islets  
(% of endocrine cells) 
 β-cells α-cells δ-cells β-cells α-cells δ-cells 
In situ  59 25 16  61 29  10 * 
In vitro (intact)  69 19 12 65  24 * 11 
In vitro(dissociated) 74 17 9 70  24 * 6 
The proportion of β-, α-, and δ-cells in small and large islets were compared in isolate intact 
islets (in vitro, intact), isolated islets dissociated into single cells (in vitro, dissociated), and in 
pancreatic sections (in situ). (* indicates a statistically significant difference for the individual 
cell type between large and small islets; p < 0.05) 
 
 
Table 2. The density of cells in small and large islets 
Islet Diameter (μm) Cells per islet (mean ± SE) Cells/IE 
Small (50μm) 83 ± 22 2235 
Large (200μm) 2071 ± 75          874 ** 
The number of cells dissociated from small or large islets were counted and calculated as 
cells/volume (IE). Small islets contain significantly more cells per volume than large islets.  
(**p < 0.001). 
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The cellular make-up of the large and small islets was analyzed after isolation (Figure 9C & 
D). Again, 65-69% of the stained cells were β-cells ( 
Table 1). The isolated large islets had a higher proportion of α-cells than isolated small 
islets, but the difference was minor and did not appear to be enough to alter the total insulin 
secreted from this population of islets (Table 1). Unlike humans, the rat islet architecture is 
organized with α- and δ-cells localized to the periphery, while β-cells were predominately found 
in the center of the islet. In the large islets, three to four layers of α- or δ-cells were located at the 
periphery in situ (Figure 9A & B). There was a clear loss of the peripheral α- and δ-cells after 
isolation (Figure 9C & D). This loss of peripheral cells was likely due to the isolation process, in 
agreement with the results of others (el-Naggar et al., 1993; Morini et al., 2006). 
 One limitation with the analysis of serial sections is that it is possible to miss or 
over-count certain cell types, because of the 2-D properties of the preparation. To overcome this 
limitation, we repeated the experiments using islets from the two populations dissociated into 
single cells and labeled for cell types. The results show that there was no significant difference in 
the proportions of β-cells to other endocrine cells between small and large islets ( 
Table 1). Finally, we co-stained isolated islets with insulin antibodies (to identity β-cells) and 
DAPI (to stain nuclei, providing a total cell count). There was no significant difference in the 
proportion of β-cells to total islet cells between small (47%) and large (50%) islets. Thus, the 
first hypothesis of a greater proportion of β-cells in small islets compared to large islets proved to 
be false.  
Islet cell density 
While the proportion of α-, β- and δ-cells within islets from the two populations was not 
different, we hypothesized that the total cell density might be greater in small islets, leading to a 
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higher total number of β-cells per small islet volume. Immunofluorescence of islets in pancreatic 
sections and after isolation showed that small islets consistently had a higher endocrine (α-, β- 
and δ-cells) cell density that was significantly greater than large islets (Figure 10A). Isolated 
small and large islets viewed with transmission electron microscopy (TEM) illustrated a higher 
total cell density in small islets compared to large (Figure 10B).  
As described above, the inherent limitations when counting cells within a 2-D image 
required that we verify the results with a third method. Thus, we isolated 293 islets with 
diameters of either 50 or 200 μm. The islets were dispersed into single cells, and the number of 
cells/islet counted. Using this method, the total cell count per volume was recorded. The density 
of cells was calculated as the total number of cells/volume (IE) of the original islets (Table 2). 
Again, the results demonstrate that the total number of cells/volume of islets was greater in the 
small than large islets. In summary, immunofluorescence (in situ and in vitro), calculations from 
TEM micrographs (in vitro), and the counting of dispersed cells all agreed that the small islets 
had a higher cell density. 
Insulin Content 
With a greater total cell density in the small islets, we hypothesized that the insulin content 
stored within individual β-cells could be greater in cells from small islets compared to large islets.  
To test this hypothesis, we utilized three approaches; the density of insulin granules from 
isolated islets was calculated from TEM, the total insulin content of isolated islets was 
determined by ELISA, and the in situ insulin content per islet and per cell was calculated with 
immunohistochemistry. 
The mean insulin granule density (granules/area) was calculated from β-cells within large 
islets and small islets. Figure 11 illustrates the differences in granule density between small (A) 
and large (B) islets. There was a statistically significant increase in the average density of insulin 
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granules in the small islets compared to large islets (Figure 11C). Our granule counts are 
consistent with published figures using the same methods (Yorde & Kalkhoff, 1986). 
Further confirmation was obtained by analyzing the total intracellular insulin content of 
isolated islets. Again, more total insulin per volume (IE) was measured in small islets compared 
to the large islets under both basal conditions (low glucose) and following a 30 min in vitro high 
glucose exposure (Figure 11D). To test insulin content in situ, pancreatic sections were stained 
for insulin and the intensity of the immunohistochemistry stain/islet was quantified. Once more, 
the insulin content was greater in the small islets (Figure 11E). Thus, using three independent 
approaches from both in situ and in vitro preparations, evidence supported the hypothesis that 
small islets contain more insulin per volume or area than large islets.  
Interestingly, normalization of the glucose-stimulated insulin release as a percentage of the 
total insulin content of the islets demonstrated that large and small islets actually secreted the 
same percentage of their total insulin content over time (Figure 11F). The difference in absolute 
insulin secretion levels was not likely due to secretory mechanisms, but rather in the increased 
insulin stored within the β-cells of the small islets.   
 
 
  39
 
 
         
 
Figure 10. Cell density higher in small islets. (A) The density of α-, β-, and δ-cells within 
small and large islets were calculated as cells/area from immunofluorescent images of pancreatic 
sections (in situ) and from isolated islets (in vitro). (B) The total cellular density was measured 
from TEM micrographs of isolated islets. (* p < 0.05) and (** p < 0.01)  
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Figure 11. Small islets have greater insulin content than large islets. (A) Typical TEM 
micrograph showing β-cells from small islet with densely packed insulin granules. (B) Typical 
β-cells from large islet with fewer insulin granules. Scale bar = 2 μm for images A and B. (C) 
β-cells from isolated small islets have a greater density of insulin granules than β-cells from large 
islets (p < 0.001). (D) Total insulin content from small (black bars) and large (gray bars) isolated 
islets (measured by ELISA) showed that small islets, in low or high glucose, contained more 
insulin per volume (p < 0.05).  
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Figure 11(cont.). Small islets have greater insulin content than large islets. (E) Insulin 
labeling intensity of islets in situ also demonstrated higher values for β-cells from the small islets 
compared to large islets (p < 0.05). (F) After normalizing insulin secretion to total insulin 
content/islet, there was no statistical difference in the level or timing of the first or second phase 
insulin secretion amount between large and small islets.   
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Insulin Location 
Immunohistochemistry demonstrated a stark difference in the intensity of insulin staining 
depending on the location of the β-cell in the islet. We analyzed the intensity of the insulin 
immunostaining per cell within the islets. In small islets all β-cells contained approximately the 
same level of insulin staining (Figure 12A). In large islets, insulin-containing β-cells located at 
the periphery of the islets contained approximately the same level of insulin per cell as those 
within the small islets (Figure 12B). However, β-cells located within the core of the large islets 
contained significantly less insulin per area (Figure 12B & C). This observation was extremely 
reproducible with 100% of the examined large islets illustrating the insulin-prominent outer layer 
of cells. Due to the inherent variation in staining intensity, comparisons were made within 
preparations. Figure 12C shows the results from one animal, but is representative of three 
independent replications. Because these findings had not been reported previously, we undertook 
a series of experiments to confirm the results. We stained serial sections of the pancreas for 
insulin using a 3-amino-9-ethyl-carbazole or a 3,3’-diaminobenzidine chromogen substrate to 
visualize staining. Both resulted in less insulin staining in the core cells of the large islets. 
Subsequently, we repeated the experiments using three different insulin antibody dilutions (1:50, 
1:100, and 1:200) to be sure that the lighter insulin staining in the core was not an artifact of the 
procedures. With all three dilutions, the results were the same; the insulin staining of the core 
cells within the large islets was less compared to the periphery and compared to the cells of small 
islets. The same characteristic, low insulin-containing β-cells in the core of large islets, was 
noted in isolated islets in culture. In large islets, insulin-secreting β-cells located at the periphery 
of the islets contained more insulin than the cells located within the central core (results not 
shown).  
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TEM analysis of the insulin-containing vesicles in β-cells from the core of the large isolated 
islets compared to the periphery supported the immunohistochemistry results. Figure 13A & B 
illustrate typical sections from the core (A), and periphery (B) of a large islet. The density of 
secretory granules was calculated by counting the number of granules/defined area and the 
results are shown in Figure 13C. There were statistically more secretory granules in the β-cells of 
the peripheral cells when compared to the core cells of the large islets. Thus, the differences in 
intracellular insulin content between large and small islets appears to be at least partially due to a 
lower amount of insulin in the β-cells within the core of the large islets.   
Characteristics of core β-cells in situ 
Because most explanations concerning the functional differences between large and small 
islets focus on the core cell death found in isolated large islets, and we identified inferior insulin 
content in large islets in situ, we examined the general characteristics of the core β-cells within 
the large islets using TEM. Using previously published methods to quantify the quality of 
mitochondria with electron micrographs (Y. Searls, I. Smirnova, B. Fegley, & L. Stehno-Bittel, 
2004), we determined that 92% of the mitochondria from β-cells of large islets were completely 
intact (grade 1) with the remaining 8% scored as grade 2 (< 50% disruption of inner 
mitochondrial membrane). No mitochondria from β-cells within large or small islets contained 
compromised mitochondria (grade 3-5). There was no difference in the mitochondrial scores for 
the cells from large or small islets. Thus, cell damage during tissue processing could not explain 
the poor insulin staining in the core of the large islets. 
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Figure 12. Core β-cells of large islets have less insulin than peripheral β-cells in situ. (A) 
Typical small islet showing dark insulin staining (brown) throughout the islet. (B) Typical large 
islet contains lighter insulin-stained β-cells at the core of the islet. (C) Analysis of single cells 
illustrates that the core β-cells of the large islets contain less insulin/cell. (** p < 0.001)   
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Figure 13. Core β-cells of large islets have less insulin than peripheral β-cells in vitro. (A) 
Typical β-cells from core of large islet with few insulin granules/area. (B) Typical β-cells from 
periphery of large islet with a higher density of insulin granules. (Scale bar = 2 μm for both 
images) (C) Analysis of cells from core and periphery of large islets showed statistically greater 
insulin granules/area in the peripheral region. (** p < 0.001) 
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2.4. Discussion 
In 1979 Baeten et al. described different islet architecture associated with islets located in 
regions of exocrine tissue that drained into different ducts (Baetens et al., 1979).They concluded 
that their research contradicted the widely-held belief that all islets have similar composition. 
Since that time, numerous labs have extended the description of morphological differences in 
islet populations to quantifiable functional outcomes. The functional differences previously 
described between isolated large and small islets have been impressive. For example, stimulation 
by high glucose (20 mM), caused a release of insulin that is 6 times higher in the small compared 
to large islets (MacGregor et al., 2006; Williams et al., 2010). Such results have been verified in 
human and mouse islets (Lehmann et al., 2007; Su et al., 2010). Other differences between the 
populations that we have identified suggest that isolated small islets have: 1) greater oxygen 
uptake, 2) better survival in culture, and 3) superior diffusion properties (MacGregor et al., 2006). 
However, all of these characteristics could be due to the manner in which the two populations 
tolerate the isolation procedures, and thus could have no relevance to the in vivo condition.   
With the work described here, we have shown that small islets have a greater cell density in 
vitro and in situ, and a greater insulin content in vitro and in situ. These results suggest that at 
least some of the functional and morphological differences noted between the large and small 
islets in vitro, are present in vivo. Further, the results supply the first mechanistic explanation for 
the differences in insulin secretion between the populations, other than large islets are more 
susceptible to core cell death. The concept that core cell death of large islets is responsible for all 
functional differences between large and small islets is no longer valid, as methods that improve 
the diffusion barrier of large islets reversed core cell death, but did not reverse the poor insulin 
secretion phenotype of the large islets (Williams et al., 2010). 
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We tested several hypotheses to determine how small islets secreted more insulin per 
volume. First, we questioned whether small islets contained a greater percentage of β-cells 
compared to large islets, thus making them more efficient insulin-secretors. However, our results 
showed that there was no difference in the cellular composition between large and small islets in 
vitro or in situ. Therefore, a greater percentage of insulin-producing β-cells cannot explain the 
superior insulin secretion in small islets. Next, we hypothesized that each β-cell within the islet 
was more efficient at releasing insulin. For the first time, we showed that cells of small islets 
contained more total insulin than cells from large islets. Thus, the two populations of islets 
actually secrete the same percentage of their total insulin, but cells from large islets store far less 
insulin to be released. More specifically, the β-cells found in the core of the large islets have a 
lower insulin content compared to the peripheral cells or the β-cells found in small islets. 
Functional differences in the core and peripheral β-cells has been described previously in vivo 
and in vitro with core β-cells containing fewer insulin granules after stimulation (Salomon & 
Meda, 1986; Stefan et al., 1987). 
The two most important findings were that the total number of cells per islet area was 
greater in small islets and the average β-cell contained more insulin than cells from large islets. 
Although the small islets account for a vast majority of the total number of islets, they make up 
only a very small percentage of the total islet volume. From this observation, many labs have 
concluded that large islets are responsible for the bulk of the pancreatic endocrine function 
(Hellman, 1959b; Kaihoh et al., 1986). This concept has been prevalent in the literature, with 
little functional data to support it. The finding that, on average, the cells of small islets contain 
more insulin than cells from large islets, and the in vitro data showing that small islets secrete 
significantly more insulin/volume than large islets, argues for an important role for small islets in 
glucose regulation in vivo. 
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It is interesting to consider the role of different islet populations during the onset and 
progression of type 1 and type 2 diabetes. In a rat model of type 2 diabetes (fa/fa) exposure of 
islets to high glucose was more detrimental to the β-cells of the large islets than cells from small 
islets (C. B. Chan & Surette, 1999; Chang, 2002). These studies showed that large islets released 
less insulin per cell than smaller ones from the same obese animals, and significantly less than 
the islets from the lean animals(C. B. Chan et al., 1998). Additionally there were fewer 
insulin-secreting cells within the large islets of the obese rats. The authors concluded that it was 
the large islets that were predominantly affected in the obese diabetic rat and that the small islets 
maintained normal insulin secretion during the time when the large islets had become 
non-functional.(C. Chan, Saleh, Purje, & MacPhail, 2002). In studies of people with type 2 
diabetes, researchers noted a shift in cellular composition, with an increase in α-cells and a 
decline in β-cells that was particularly noticeable in the large islets (Yoon et al., 2003). 
The results presented here demonstrate that many of the characteristics associated with 
islets of different sizes after islet isolation, were consistent when examined in situ in rats. Unique 
characteristics, inherent within the pancreatic tissue of rats, included a higher density of cells in 
the small islets with greater insulin content. Different islet populations may have important 
distinctions, many of which are yet to be characterized, but which may be necessary for a healthy 
endocrine pancreas. 
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Chapter 3                     
Total Cell Number- A Superior Model for 
Volume Quantification of Isolated Islets  
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3.1. Abstract 
 Islet equivalent (IE), the standard estimate of isolated islet volume, is based on the 
assumption that all islets are spherical. Yet, certain populations of islets are ellipsoidal, creating 
errors in volume quantification. Here, we developed and tested a new easy-to-use method to 
quantify islet volume with greater accuracy. Isolated rat islets were dissociated into single cells 
and the total cell number per islet were determined by using a computer-assisted cytometry. 
Based on cell number per islet, we created a regression model to convert islet diameter to cell 
number with a high R-squared value and a good validity and reliability. An inverse correlation 
between the cell number per IE and islet size was identified. Overall, IE measurement 
overestimated the tissue volume in islets with diameter above 150µm suggesting that the larger 
the islet, the greater the error in IE values. To compare results obtained using IE or our new 
method, we compared Glut2 protein levels determined by immunoblotting and proinsulin content 
via ELISA between small (diameter ≤ 100µm) and large (diameter ≥ 200µm) islets normalized 
by standard IE counts or our new cell number method. When normalized by IE, large islets 
showed significantly lower Glut2 level and proinsulin content. However, when normalized by 
cell number, large and small islets had no different Glut2 levels, but large islets contained more 
proinsulin. In conclusion, normalizing islet volume by IE overestimated the tissue volume in 
large islets, which may lead to some erroneous results. Normalizing by cell number is a more 
accurate method to quantify tissue amount used in islet transplantation and research.
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3.2. Introduction 
 Islets of Langerhans are spherical-like clusters of endocrine cells that have a large range 
of sizes from 20µm to more than 400µm in diameter both in rodent (MacGregor et al., 2006) and 
humans (Buchwald et al., 2009; Ricordi, Socci et al., 1990). An accurate and consistent method 
to quantify the amount of tissue being used in experiments is of crucial relevance for islet 
research and transplantation. Early experimental results were incomparable between laboratories 
until the islet equivalent (IE) was suggested by Ricordi et.al. in 1990 at the Second Congress of 
the International Pancreas and Islet Transplantation Association (Ricordi, Gray et al., 1990). One 
IE corresponds to the tissue volume of a perfectly spherical islet with a diameter of 150μm. In 
the standard measurement procedure, a sample islet preparation is stained with dithizone 
(diphenylthiocarbazone) to discriminate islet from exocrine tissue. Under light microscopy with 
an ocular micrometer, a single diameter of islet is directly measured manually by the operator. 
Next, islets are categorized according to their diameters within 50-µm increments and the 
number of islets in each category is multiplied by a related conversion factor that convert the 
islet number and diameter to IE (Ricordi, 1991; Ricordi, Gray et al., 1990).  
 Currently, IE is the most common measurement used both in the clinic and in the 
laboratory. At transplantation sites, IE is a rapid measurement for quantifying the dosage of the 
transplanted material. The IE is used to estimate the yield of islets isolated from the donor, and 
the IE per kilogram of body weight is the unit commonly used to report the graft amount 
transplanted to the patient (Balamurugan et al., 2010; Bellin et al., 2011; D'Aleo et al., 2010; 
Kaddis, Danobeitia, Niland, Stiller, & Fernandez, 2010; Kessler, Bakopoulou et al., 2010; 
Kessler, Greget et al., 2010; Lehmann et al., 2007; Matsumoto et al., 2010; Niclauss et al., 2011; 
O'Gorman et al., 2010; Ris et al., 2011; T. Saito et al., 2010; Shapiro et al., 2000; Shimoda et al., 
2010a, 2010b; Sutton et al., 2010; Takita et al., 2011). In the laboratory, IE is commonly applied 
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to normalize the amount of islets between preparations for functional assays such as insulin 
secretion (Fujita et al., 2011; H. H. Huang, L. Novikova, S. J. Williams, I. V. Smirnova, & L. 
Stehno-Bittel, 2011; Lehmann et al., 2007; MacGregor et al., 2006; Williams et al., 2010). 
 Recently, the accuracy, repeatability and intermediate precision of standard IE 
measurement procedure were tested in a multi-center study (Kissler et al., 2010). However, the 
results were very disappointing. For example, more than 50% of centers overestimated the IE 
count on the same (photographic) samples compared to the expert standard. The intra-technician 
coefficients of variation (CVs) from one repeat count in the 35 technicians participating, which 
were calculated to assess the repeatability, ranged from 0 to a maximum of 42.5% and 
approximately 30% of technicians had a CV% over 10%. In addition, the inter-technician CVs 
within each center were used to assess the intermediate precision, and the average 
inter-technician CV% was around 15%. Overall, these results indicated that the validity and 
reliability of IE measurement were unsatisfying.    
 In fact, the accuracy of IE measurement has been challenged for years (Buchwald et al., 
2009; Fetterhoff, Wile, Coffing, Cavanagh, & Wright, 1994; Kissler et al., 2010; Niclauss et al., 
2008; Pisania, Papas et al., 2010; Pisania, Weir et al., 2010; van der Burg, Scheringa, Basir, & 
Bouwman, 1997), because the IE calculations are based on the assumption that all islets are 
spherical; an assumption that has already been suggested to be incorrect (Cummings et al., 2008; 
Girman et al., 2008; Lehmann et al., 1998; Niclauss et al., 2008; Perez-Armendariz, Atwater, & 
Rojas, 1985; Pisania, Papas et al., 2010; Ricordi, Socci et al., 1990). In reality, most islets are 
disk-shaped oblate ellipsoid or irregular shapes, especially in culture. A measurement of the 
three largest dimensions in mutually perpendicular directions of the isolated islets has been 
reported. In a perfect sphere, the three major radii a, b and c would equate to a = b = c.  
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However, the average measured ratios of b/a is 0.82 and c/a is 0.6 suggesting that islets are more 
like ellipsoids (Avgoustiniatos, 2002).  
Several digital image analysis methods were proposed to replace manual estimation to 
improve quality assurance of islet product for transplantation (Friberg et al., 2011; Girman et al., 
2008; Girman, Kriz, Friedmansky, & Saudek, 2003; Kissler et al., 2010; Lehmann et al., 1998; 
Lembert et al., 2003; Niclauss et al., 2008; Stegemann, O'Neil, Nicholson, & Mullon, 1998; 
Stegemann, O'Neil, Nicholson, Mullon, & Solomon, 1997). By photographing islets digitally, the 
area and diameter of each islet were measured by computer and the islet volume (IE) was 
calculated accordingly. In addition, Buchwald, et al. recently proposed a refinement of current IE 
measurement to improve the accuracy (Buchwald et al., 2009). However, most of these efforts 
were still based on the assumption that islet is a sphere. Therefore, we suggested either 
one-dimensional (longitudinal axis) or two-dimensional (area) approach of IE measurement used 
currently is oversimplified, leading to an inaccuracy when estimating the actual tissue amount of 
a three-dimensional islet.  
In the present study, we developed and tested a new method for estimating islet volume 
based on cell number counts. We completed validity and reliability studies on our new method 
and showed that it is a fast, more accurate and reliable method of estimating islet volume. These 
efforts are relevant to improving the accuracy of measure of transplanted tissue volume, and 
assuring that erroneous results are not reported in the literature.
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3.3. Methods 
Rat islet isolation, separation and IE measurement  
Adult male and female Sprague Dawley rats (200~350g BW) were housed on a 12 hours 
light/dark cycle with free access to standard laboratory chow and water. All animals received 
care in compliance with the Principles of Laboratory Animal Care formulated by the National 
Society for Medical Research and the Guide for the Care and Use of Laboratory Animals 
published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996). 
Islet isolation methods followed our published procedures described in detail (H.-H. Huang 
et al., 2011; MacGregor et al., 2006; Williams et al., 2010; S. Williams et al., 2009). Briefly, rats 
were anesthetized by intraperitoneal injection of a mixture of ketamine and xylazine. After the 
peritoneal cavity was exposed, the pancreatic main duct to the intestine was clamped and the 
pancreas cannulated in situ via the common bile duct. The pancreas was distended with 
collagenase and removed. Islets were gently tumbled, washed, and passed through a sterile 30 
mesh stainless steel screen and centrifuged. The pellet was mixed with Histopaque, centrifuged, 
and the islets floating on the gradient were collected and sedimented. Islets were passed through 
a sterile 40µm mesh cell strainer with HBSS. After this cleaning process, islets were placed into 
CMRL1066 medium containing 2 mM glutamine, 10% fetal bovine serum (FBS) and 1% 
antibiotic/ antimycotic solution or DMEM/F12 medium (17 mM glucose) containing 10% FBS, 
20 ng/ml epidermal growth factor (EGF) and 1% antibiotic/ antimycotic solution and put into a 
37ºC culture chamber containing 5% CO2. For manual separation of islets, the islet culture media 
was changed to L15 containing 10% FBS and 5mM HEPES, and islets were transferred into 
37ºC culture chamber without CO2. Islets were manually separated by size based on the criteria 
that small: diameter ≤ 100µm; large: diameter ≥ 200µm. After measuring the IE, the selected 
islets were frozen by liquid nitrogen and preserved in -80 ºC until being used. 
 
  55
The IE measurements for each preparation followed our previously published procedures (H. 
H. Huang et al., 2011; MacGregor et al., 2006; Williams et al., 2010). Briefly, the diameter of 
each islet was recorded manually using light microscopy with an ocular micrometer at 40X total 
magnification. For irregularly shaped islets, two to four diameter measurements were taken at 
different locations on the islet and averaged. The volume of each islet was calculated based on 
the diameter and converted to IE individually, where one IE is equal to 1.77 x 106 µm3 ( the 
volume of a spherical islet with 150µm diameter) (Buchwald et al., 2009; Fujita et al., 2011; 
Niclauss et al., 2008; Stegemann et al., 1998; van der Burg et al., 1997).  
Islet dissociation and cell number estimation 
For single cell assays, isolated islets were picked manually and individually distributed into 
a well of a 96-well black plate with clear bottom (Corning® No.3603) in medium containing 
calcium-magnesium free HBSS. After recording the diameter of each islet as described above, 
the islets were dissociated into single cells using our published protocol (H.-H. Huang et al., 
2011; S. Williams et al., 2009). Briefly, after adding concentrated papain into each well with a 
final concentration of 5 U/ml, islets were incubated at 37°C for 20 min. Following that, the islets 
were dispersed into single cells by repeated pipetting and the dissociated cells in the wells were 
spun down in the plate with 300 rpm for 1 min at room temperature. The cell number in each 
well was analyzed using Celigo™ adherent cell cytometer with following procedure. Every well 
containing single cells was photographed digitally and the cells were counted using the Celigo 
software (1.3). Cells were counted from at least 340 islets from both male and female rats with 
two different ages (two month-old or six month-old). In addition, all islets were cultured in either 
CMRL1066 or DMEM/F12 medium overnight before being used.   
To test the reliability of the cell count, manual counts using a hemocytometer were 
performed. Islets were grouped manually into size categories based on diameters. The number of 
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islets in each group was recorded before dissociating the islets into single cells based on our 
published protocol. A 10 µl sample of dispersed cells was loaded into a hemocytometer for cell 
counting. Six repetitions were performed in each sample set.  
Total protein yield 
 Islets within groups were homogenized using a 26G1/2 syringe with extraction buffer 
containing 10mM TRIS HCl pH7.4, 150mM NaCl, 1mM EDTA, 20mM Na Molybolate, 50mM 
Na Fluoride, 0.2mM Na-Orthovanidate (pH 10), 1% Triton X-100, and 0.2mM PMSF. The 
extracts were centrifuged for 15 minutes with 15,600 rcf at 4°C. Measurement of protein 
concentrations in supernatants was performed using Micro BCA Protein Assay Kit (Pierce, 
Rockford, IL, U.S.A., #23235). 
Total DNA yield 
 In the total protein per DNA study, the small or large islets were further aliquoted evenly 
into two parts for protein and DNA content measurement respectively. Islets within groups were 
lysed with lysis buffer containing 10mM TRIS HCl pH7.5, 150mM NaCl, 5mM EDTA (pH8.0), 
0.5% SDS, and 50µg/ml proteinase K, and vortexed until the cell pellet was dispersed. After 
incubation overnight at 55°C, the sample was spun at 12,000 rpm for 10 minutes at room 
temperature. The supernatant was collected and equal volume of isopropanol was added into 
each sample. After letting the sample to sit for 5 minutes, another centrifugation (12,000 rpm for 
10 minutes at RT) was performed. The supernatant was discarded, and TE buffer was added to 
dissolve the DNA with a 1 hour incubation at 55°C. The DNA concentrations were measured 
using Quant-iT™ PicoGreen® dsDNA Assay Kit (Invitrogen, Carlsbad, CA, U.S.A., #P11496). 
Western Blot 
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 Hand-picked small and large islets were washed individually in phosphate-buffered saline 
(PBS) twice. After removing the supernatant, the islets were homogenized as described 
previously. Samples from large and small islets extracts were prepared for electrophoresis by 
heating at 95 oC for 3 min in SDS gel-loading buffer (0.125M Tris, pH6.8, 5% glycerol, 2.5% 
mercaptoethanol, 2% SDS, and 0,001% bromophenol blue). Proteins were separated on a 4-15% 
Tris-HCl Ready Gels (Bio-Rad Laboratories, Hercules, CA, U.S.A., #161-1158) with 0.025 M 
Tris, 0.192 M Glycine, 0.1% SDS running buffer. Equal amounts of total protein (10 µg) were 
loaded in each lane. Molecular weight markers See Blue Plus2 Pre-Stained Standard (Invitrogen, 
Carlsbad, CA, U.S.A., #LC5925) was used to determine the size of the antigen. After 
electrophoresis, the proteins were transferred from the gel to Bio Trace PVDF membranes 0.45 
µm (Pall Life Sciences, East Hills, NY, U.S.A., #P/N 66547) using 0.012 M Tris, 0.096 M 
Glycine transfer buffer. Blots was blocked with 5% nonfat dry milk diluted in 0.1M PBS 0.1% 
Tween (PBST) for 1 hour. Primary and secondary antibodies were diluted in the 5% nonfat dry 
milk in PBST. All incubations were performed at room temperature. Blots was probed with 
primary antibodies against Glut2 (Santa Cruz Biotechnology Inc., Santa Cruz, CA, U.S.A., 
#sc-9917), for 1 hour at room temperature. After washing in 0.1M PBS 0.1% Tween (10 minutes 
for 3 times), blots were incubated for 30 minutes with secondary antibody horseradish 
peroxidase-conjugated goat anti-rabbit IgG (Santa Cruz Biotechnology Inc., Santa Cruz, CA, 
U.S.A., #sc-2004) or goat anti-mouse IgG (Santa Cruz Biotechnology Inc., Santa Cruz, CA, 
U.S.A., #sc-2005). After washing in 0.1M PBS 0.1% Tween (10 minutes for 3 times), bound 
antibodies were detected using SuperSignal® West Pico Chemiluminescent Substrate (Thermo 
Fisher Scientific Inc., Rockford, IL, U.S.A., # 34080). For a protein loading control, the 
membrane was reprobed with mouse anti-GAPDH (Sigma-Aldrich®, St. Louis, MO, U.S.A., 
#G8795), for 1 hour at room temperature.  
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Proinsulin content  
 Islet static incubation assays were followed by our published procedures (H.-H. Huang et 
al., 2011; MacGregor et al., 2006; Williams et al., 2010). Isolated islets were placed in 24-well 
plate with a minimum of 5 large or 15 small islets per well. All wells were preincubated for 2.5 
hours in RPMI 1640 containing 10% fetal bovine serum and 3 mM glucose in a 37°C containing 
5% CO2. After preincubation, media was removed and fresh media was added. After a 30 
minutes static incubation at 37°C and 5% CO2, the islets were harvested and frozen at -80°C. 
The total protein in the islets was extracted by sonication in acid ethanol (0.18M HCl in 95% 
ethanol) and incubated overnight at 4°C. The total intracellular proinsulin amounts were 
determined by the ELISA (ALPCO, Salem, NH). 
Statistics 
 The exact number of islets or replicates is shown in each figure legend. Results were 
expressed as mean of each group or cell population ± SEM, and were compared using the 
Student’s t test. The Pearson product-moment correlation was used to test the correlation 
between two cell counting techniques. Significant differences were defined as p < 0.05.
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3.4. Results 
Cell number per islet  
 The dissociated islet cells were counted using computer-assisted cytometry. The total cell 
number per islet from different sizes of islets is summarized in Table 3. No significant 
differences were seen between animals’ gender, ages or the mediums used for islet culturing. 
Based on the measured cell numbers, a third-order polynominal regression trend line was the 
best fit with the equation:  
y = -0.0001x3 + 0.0912x2 - 6.2162x + 182.1125 
where y equals the total cell number and x equals the islet diameter (µm). The R-squared value 
was 0.8, indicating the regression trend line fit the data very well.  
 Next, we compared the our measured cell number per islet with the conventional IE 
measurement by Ricordi et al. (Ricordi, Gray et al., 1990) and the refined IE measurement by 
Buchwald et al (Buchwald et al., 2009) using 1560 cells per IE as a norm, which was published 
recently by Pisania, et al (Pisania, Weir et al., 2010). The results were plotted in Figure 14A. 
Compared to the our actual cell counts, as the islet size increased, the difference between the 
actual and theoretical cell counts (using Ricordi’s algorithm with Pisania’s cell number per IE) 
was more prominent, which indicated that using currently published methods to estimate islet 
volume may overestimate the actual tissue volume per islet, especially in large islets. Even 
though Buchwald’s refined algorithm introduced a downward correction, the adjustment was 
marginal and a significant overestimation still existed (Figure 14A). In addition, we plotted 
another theoretical curve based on our actual cell count (934 cells) in a 150µm-diameter islet and 
assuming that islets are perfect sphere and all cell size are equivalent. As shown in Figure 14B, 
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Table 3. Cell number per islet estimated by computer-assisted cytometer 
Islet diameter 
(µm) 
Number of 
islets evaluated*
Cell number 
per islet 
50 25 92 ± 11 
75 48 188 ± 15 
100 40 322 ± 24 
125 36 642 ± 48 
150 33 943 ± 60 
175 46 1308 ± 68 
200 42 1674 ± 91 
225 31 2099 ± 94 
250 21 2731 ± 137 
275 7 2831 ± 216 
300 5 3586 ± 689 
325 9 4003 ± 506 
Data are presented in mean ± SEM. * The islets were harvested from 8 animals. 
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Figure 14. IE measurements overestimated the actual tissue volume in large islets.       
(A) Relation curve between islet size and actual cell number per islet (black dots) were plotted in 
the black solid line. Two theoretical curves were plotted using the Ricordi’s conventional IE 
measurement with different categories of sizes in a 50-µm increments (blue step plot) (Ricordi, 
Gray et al., 1990) and using Buchwald’s refined IE measurement (red step plot) (Buchwald et al., 
2009), based on 1560 cells per IE (volume of islet with 150µm diameter) as suggested by Pisania, 
et al (Pisania, Weir et al., 2010). (B) The two theoretical steps curves (blue and red) were slightly 
modified into curves based on the average islet diameter in each category of size and the 
theoretical estimated cell number (based on 1560 cells per IE). Additionally, another theoretical 
curve (black dash line with white dots) was plotted based on the actual cell number of a 150µm 
islet (934 cells) with the assumptions that islets are perfect sphere and all cell sizes are 
equivalent.  
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this theoretical spherical curve was overall lower than both IE measurement curves, which have 
been slightly modified from Figure 14A (based on the average islet size in each category and 
theoretical cell number per islet). However, this theoretical spherical curve was also different to 
the curve of actual cell count especially in large islets. This result may implicate that the 
assumption of spherical 150µm-diameter islet was not appropriate. 
Cell number per IE 
To further demonstrate the errors within the current IE calculations, we plotted the cell 
number within islets divided by the islet’s IE (Figure 15). If the IE calculations accurately 
reflected the true volume of the islet, then this graph should have resulted in a flat line. Rather it 
shows that as the size of the islet increased the IE calculation overestimated the true volume.  
Validity 
Total DNA content per IE and per cell 
 Small and large islets were separated manually and IE was estimated as described in the 
methods. The total cell numbers in both small and large islets were estimated by using the 
equation above. IE normalization resulted in the conclusion that small islets have significantly 
higher DNA content per IE compared to large islets (p < 0.001). However, the total DNA content, 
when calculated per cell, showed no difference (p = 0.43) in small and large islets (Table 4). The 
averaged total DNA content per cell was approximately 6.05 ± 0.69 pg, which is in agreement 
with other reports (Lernmark, 1974; Pipeleers et al., 1985; Pisania, Papas et al., 2010).  
Total protein content per IE and per cell 
 Normalization to IE resulted in the conclusion that small islets contained a significantly 
higher total protein amount than large islets (p < 0.05). However, when using the equation to 
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Figure 15. Cell number per IE. There was a negative correlation between islet size and cell 
number per IE. 
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estimate total cell number, there was no significant difference (p = 0.35) in protein content per 
cell between small and large islets (Table 5). In addition, total protein content per DNA content 
was calculated, since DNA content is commonly used for cell number normalization. No 
differences (p = 0.40) were seen in total protein per DNA between small and large islets (Table 
6), which further supported the finding that small and large islets had no difference in total 
protein per cell. 
Inter-method reliability 
 Islets were manually separated into five categories based on diameters of 50, 100, 150, 
200, and 250 µm. Figure 16 provides an example of the uniform separation that was achieved for 
each size category. After dissociation, the cell number per islet in each category was evaluated 
by using hemocytometer. The results showed a high correlation (r = 0.99) with the cell count by 
using the computer-assisted cytometer indicating a good inter-method reliability (Figure 17). 
Glut2 protein levels 
 As an example of how IE measurements can alter the conclusions one draws from an 
experiment, Glut2 and proinsulin levels were measured from small and large islets and the data 
were normalized using the traditional IE (Ricordi, 1991; Ricordi, Gray et al., 1990) and our cell 
number method.   
 To determine the Glut2 protein levels, 10 µg of protein from small and large islets were 
used for Western Blot. The representative results were shown in Figure 18A. When the blot 
densitometry was normalized to the levels of the internal control, GAPDH, there was no 
significant difference (p = 0.69) in the Glut2 protein levels between small and large islets (Figure 
18B). The IE values and total cell number that result in 10 µg of protein in the large and small 
islets were calculated based on the results shown in Table 7. The IE value per 10 µg of protein 
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was significantly higher (p < 0.05) in small islets, while the total cell number per 10 µg of 
protein was not significantly different (p = 0.37) in small and large islets (Table 7). When the 
blot densitometry was further normalized by IE, Glut2 levels were significantly higher (p < 0.05) 
in small islets than in large islets (Figure 18C). However, when normalized by total cell number, 
there was no significant difference of Glut2 protein levels (p = 0.25) between the two groups 
(Figure 18D). 
Proinsulin content 
 Proinsulin content in small and large islets was determined by ELISA. The results also 
varied based on the normalization methods. When normalized by IE, the proinsulin levels were 
significantly lower (p < 0.05) in the large islets compared to the small islets (Figure 19A). 
However, when normalized by the total cell number, the results were opposite with significantly 
higher levels (p < 0.05) in the cells of the large islets compared to the small (Figure 19B).
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Table 4. Total DNA content per IE and per cell in small and large islets 
 Small Islets Large Islets p value 
DNA (pg) / IE 8.19 ± 1.12 3.62 ± 0.70 <0.001 
DNA (pg) / Cell 6.17 ± 0.97 5.93 ± 1.00 0.43 
Data are presented in mean ± SEM. For small islets, N = 21 experiments from 6 rats. Each 
experiment contained at least 50 small islets. For large islets, N = 20 experiments from 6 rats. 
Each experiment contained at least 20 large islets. 
 
Table 5. Total protein content per IE and cell in small and large islets 
 Small Islets Large Islets p value 
Protein (µg) / IE 0.82 ± 0.07 0.50 ± 0.08  < 0.05 
Protein (ng) / Cell 0.58 ± 0.06  0.69 ± 0.10  0.35 
Data are presented in mean ± SEM. For small islets, N = 4 experiments. Each experiment 
contained at least 450 small islets from 1 rat. For large islets, N = 4 experiments. Each 
experiment contained at least 50 large islets from 1 rat.  
 
 
Table 6. Total protein content per DNA in small and large islets 
 Small Islets Large Islets p value 
Protein (µg) / DNA (ng) 0.13 ± 0.00  0.12 ± 0.01 0.40 
Data are presented in mean ± SEM. N = 4 experiments from 2 rats. Each experiment contained at 
least 250 small islets or 20 large islets. 
 
Table 7. IE and total cell number in 10µg of protein in small and large islets. 
 Small Islets Large Islets p value 
IE / 10µg protein 12.43 ± 1.12  21.84 ± 3.35  < 0.05 
Cell / 10µg protein 17855 ± 1698 15379 ± 1910 0.37 
Data are presented in mean ± SEM. N = 4 samples. Each sample contained more than 450 small 
islets or 50 large islets from 1 rat. 
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Figure 16. The isolated rat islets. The isolated islets with high purity were manually separated 
with specific size (diameter of 50, 100, 150, 200 and 250 µm).  
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Figure 17. Correlation between cell count using hemocytometer and the computer-assisted 
cytometer. In the hemocytometer, N = 3 samples in each group with identical size of islets. Each 
sample contained more than 256 islets in 50 µm, 94 islets in 100 µm, 83 islets in 150 µm, 37 
islets in 200 µm or 16 islets in 250 µm from 2 adult male rats. The hemocytometer data were 
correlated with the data showing in Table 3. 
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Figure 18. Glut2 protein levels in small and large islets. The representative bands done by 
Western Blot were shown in (A).The blot densitometry was normalized to internal control 
GAPDH (B), GAPDH and IE (C), GAPDH and cell number (D) . N = 5 experiments, each 
experiment contained at least 1,500 small islets or 300 large islets from 6 adult male rats. (*, p < 
0.05) 
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Figure 19. Proinsulin content in small and large islets. When normalized by IE (A), small 
islets showed a higher proinsulin content. When normalized by cell number (B), the results were 
opposite showing that large islets had a higher proinsulin content. N = 3 experiments, each 
experiment contained two replicates with at least 16 small islets or 6 large islets per replicate 
from 2 adult male rats. (*, p < 0.05) 
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3.5. Discussion 
 The accuracy of the international-standardized IE measurement has been questioned for 
years. Several factors which may affect the accuracy have being recognized such as subjective 
judgment of the examiners, sampling techniques and islet purity. While most research groups 
were engaged in studying computer-assisted digital image analysis (DIA) to compensate these 
disadvantages, the accuracy of the algorithm that converting islet size into IE was paid little 
attention until recently. Buchwald, et al. suggested that the algorithm, first proposed by Ricordi 
et al., overestimated total IEs by 4~8%. Accordingly, they proposed a modified conversion 
factors to estimate IE (Buchwald et al., 2009). However, here we showed both conventional IE 
measurement and the Buchwald’s refined measurement overestimated the actual tissue volume 
especially in large islets. It has been suggested that grouping islets into a 50-µm range in current 
standard procedure might lead to a overestimation in IE (Buchwald et al., 2009; Niclauss et al., 
2008). We suggest that the incorrect assumption that islets are spheres in the current algorithm 
causes IE measurement inaccuracy, because many research groups, in addition to us, have 
recognized that shapes of islets are irregular (Cummings et al., 2008; Girman et al., 2008; 
Lehmann et al., 1998; Niclauss et al., 2008; Perez-Armendariz et al., 1985; Pisania, Papas et al., 
2010; Ricordi, Socci et al., 1990).  
 Since islets are cluster of cells, we proposed to estimate islet tissue volume by total cell 
number. Recently, Pisania et al. estimated the islet volume by using cell nuclei count. They 
concluded an overestimation when using IE measurement and suggested the overestimation 
might be due to the possible space such as intra-islet vessel and intracellular space not accounted 
for by IE measurements (Pisania, Weir et al., 2010). Compared to Pisania’s work, we also base 
our volume estimations on cell numbers, but our approach does not require an extra step in the 
experimental process (nuclei isolation and staining). 
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 We developed a regression model to estimate the number of cells per islet over a wide 
range of islet diameters with a high R-squared value and a good validity and reliability. When 
comparing the standard IE measurement to our method using cell number, we identified a 
significant overestimation of tissue volume in large islets by using IE calculations. The inverse 
correlation between total cell number per IE and islet size can explain this finding, because when 
normalized total cell number to IE, there were fewer cells per IE in large islets compared to small 
islets, which might be due to there are more intracellular space and vessels in the large islets as 
described previously. (Pisania, Weir et al., 2010).      
 Current islet volume normalizing methods in islet research need to be reconsidered, 
because completely different results may be obtained depending to the normalization methods. 
Here, we provide examples of Western Blot to study the Glut2 protein levels and ELISA to 
report proinsulin content comparing small and large islets. We show contradicting results based 
solely on the normalization method used. Since total protein content per IE was different in small 
and large islets, normalizing any protein by IE is not correct. Instead, normalizing by total 
protein amount used in the experiment (such as an internal control) and/or normalizing by total 
cell number produces more accurate results.  
 Our findings may have a tremendous impact on assumptions made about the volume 
versus size of islets within the rat pancreas. It is frequently reported that large islets (diameter 
>150µm) comprise 47% of total volume of endocrine tissue from the pancreas, even though they 
come from a relative small number count (5% of the total number of islets) (Korsgren et al., 
2005). Moreover, when considering islets of 100µm in diameter and greater, it is thought that 
they make up 20% of the total number of islets but nearly 75% of the total islet volume 
(Korsgren et al., 2005). However, those estimates are based on Hellman’s early work that still 
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considered islets as mainly spherical (Hellman, 1959a). Thus, the actual percentage of volume 
defined by large islets may be less and needs to be reconsidered.  
 In clinical transplant settings, the implications are immediate. Large islets are 
preferentially used for transplantation due to their relatively high assumed tissue volume. 
However, the volume of large islets has to be assessed more carefully, because recently the high 
variability in IE measurement due to large islets has been recognized by others (Buchwald et al., 
2009). We suggested that if one calculates the typical volume of islets transplanted during the 
process, and corrects it based on Figure 14A, then the actual volume transplanted will be 
significantly less. In order to freely distribute the method described here for researchers, we 
created a spreadsheet that automatically calculates cell number from the measured islet diameter. 
The spreadsheet is available online for free public downloads. 
 In conclusion, the assumption of spherical islets used by conventional IE measurement 
has been shown to be incorrect. IE measurement overestimated the islet volume, potentially 
affecting the results of islet research and transplantation. We established a new method to 
estimate islet volume via the total cell number per isolated islet in rats. This model needs to be 
further established in humans to better estimate the tissue volume used in human islet research 
and transplantation. 
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Chapter 4                     
The insulin biosynthesis pathway in small 
and large islets does not correspond to 
insulin secretion 
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4.1. Abstract 
 Insulin is produced and released from the β cells of pancreatic islets through a cascading 
pathway from insulin gene transcription to proinsulin biosynthesis to insulin secretion. The 
elevation in glucose concentration is the primary signal to activate each step respectively through 
a complex network of intracellular signaling pathways. Small islets are thought to have more 
insulin secretion when compared to the same tissue volume of large islets. However, the possible 
unique mechanisms of glucose-stimulated insulin production and secretion between small and 
large islets are unidentified. In the present work, we challenged the isolated small and large rat 
islets with 30 minutes high glucose and compared the responses of insulin gene transcription 
(including the preproinsulin mRNA and insulin gene transcription factors: NeuroD/ Beta2, MafA 
and PDX-1), proinsulin and insulin synthesis, and insulin secretion between large and small 
islets. The results showed that levels of Glut2, the glucose transporter in β cells, were not 
different between large and small islets. In transcription level, 30 minutes of high glucose did not 
alter the preproinsulin mRNA (insulin 1 and insulin 2) and the gene expressions of NeuroD/ 
Beta2 and MafA. Yet, 30 minutes high glucose suppressed the PDX-1 gene expression in protein 
levels in both small and large islets. In translation level, 30 minutes of high glucose significantly 
increased the proinsulin levels, and large islets showed a higher proinsulin content per cell under 
high glucose. However, insulin content per cell was not significantly different between small and 
large islets under high glucose. Surprisingly, the glucose-stimulation insulin secretion was not 
significantly different between small and large islets when normalized by cell number, even 
though higher stimulation index was seen in large islets. Interestingly, when comparing small 
and large islets under basal conditions by t-test, higher NeuroD/Beta2 and MafA gene 
expressions in both protein and mRNA levels were seen in the large islets, but with a lower of 
PDX-1 protein levels, when compared to small islets. In summary, the difference in insulin gene 
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transcription between small and large islets can not be identified under short period glucose 
stimulation. In spite of what appears to be upregulation of the proinsulin biosynthesis in large 
islets, these changes did not correspond to insulin content and insulin secretion levels. Therefore, 
when comparing large and small islets, there might be disconnections between the insulin 
biosynthesis pathway and insulin secretion levels.  
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4.2. Introduction 
Insulin, an important hormone for blood glucose hemostaisis in mammals, is produced 
through a cascading process in the β cells of pancreatic islets. Through gene transcription, the 
insulin gene is transcribed from DNA to preproinsulin mRNA. Following that, the preproinsulin 
mRNA is translated into preproinsulin protein, which exists the cell shortly. Then, the 
preproinsulin is processed into proinsulin and stored into granules. The proinsulin is cleaved by 
specific enzymes into c-peptide and insulin. Finally, the mature insulin is released from the cell 
by exocytosis to the blood stream.  
 The elevation in blood glucose concentrations is the primary signal for insulin production 
and secretion. By entering into the β cell via the glucose transporter (Glut2) on the plasma 
membrane, glucose is thought to enhance insulin biosynthesis (including gene transcription and 
translation) and insulin release through the complex network of intracellular signaling pathways.  
 At the transcription level, it is suggested that high glucose (16.7 mM) stimulates insulin 
gene transcription about 3-fold after 10 minutes, and the transcriptional activity is maximal at 30 
minutes, but markedly decreased thereafter (Efrat et al., 1991). Leibiger, et al. also reported that 
incubating the isolated islets in a high glucose (16.7 mM) for only 15 minutes, resulted in a 2 to 
5- fold elevation in preproinsulin mRNA levels within 60~90 minutes. The authors also 
suggested that the glucose stimulatory effect is most obvious 30 minutes after the glucose 
exposure, but declines thereafter (Leibiger et al., 1998). Therefore, it is likely that the production 
of preproinsulin mRNA is affected by high glucose concentration within minutes. In addition, 
increased glucose levels activate upstream signals that are responsible for the activation of the 
transcription factors involved in insulin gene transcription, which are the homeodomain protein 
pancreas duodenum homeobox-1 (PDX-1), Beta-cell E-box trans-activator 2 (Beta2 or NeuroD) 
proteins, and the basic region leucine zipper MafA. Glucose stimulates PDX-1 translocation and 
 
  77
increases PDX-1 DNA binding activity through the pathway involving phosphatidylinosito 
3-kinase (PI3-K) activation (Elrick & Docherty, 2001; MacFarlane et al., 1994; Macfarlane et al., 
2000; Rafiq et al., 2000; Rafiq et al., 1998). Glucose also stimulates the binding activity of 
Beta2/NeuroD to the insulin promoter (E1) in β cells, which is dependent upon the 
phosphorylation of extracellular signal-regulated kinase (ERK) 1/2 (Khoo et al., 2003; Lawrence 
et al., 2005; Naya et al., 1995). In addition, glucose stimulates MafA expression and activates 
binding activity of MafA to the insulin promoter (C1) to enhance insulin gene transcription 
(Hagman et al., 2005; Kataoka et al., 2002; Zhang et al., 2005). 
At the translational level, glucose is the most physiologically relevant factor that regulates 
the proinsulin synthesis. Glucose stimulates the recruitment of preproinsulin mRNA from an 
inert cytosolic pool to the rough ER, the site of preproinsulin protein synthesis (Itoh & Okamoto, 
1980; Welsh et al., 1986). After one hour of incubation at high glucose (16.7 mM), proinsulin 
protein levels in the rat islets increases up to 6 to 15 fold (Guest et al., 1989; Wicksteed et al., 
2003). In addition, proinsulin synthesis is dose-dependent, and has been reported to increase 
25-fold when glucose is increased from 1 to 10 mM for one hour (Schuit et al., 1988).  
Insulin secretion in response to increased glucose concentrations exhibits a biphasic pattern 
consisting of a rapidly initiated and transient first phase (lasting 5~10 minutes) followed by a 
slowly developing and sustained second phase (Cerasi, 1975; Curry et al., 1968; Lacy et al., 1972; 
Luzi & DeFronzo, 1989). The insulin granule secretion rate has been reported to amount to 
0.14% and 0.05% of the total insulin content per minute in the first and second phase 
respectively (Rorsman & Renstrom, 2003). The first phase insulin release from the readily 
releasable pool, which contains less than 5% of total insulin granules per β cell, is regulated by 
glucose stimulation through the ATP-sensitive K+ (KATP) channel-dependent pathway, increasing 
Ca2+ causing insulin granule release or exocytosis (Bratanova-Tochkova et al., 2002). In the 
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second phase, glucose involves the mobilization and priming process of insulin granules from 
reserve pools, which contains more than 95% of total insulin granules per β cell, to the readily 
releasable pool to gain the competence for the sustained second phase release 
(Bratanova-Tochkova et al., 2002).  
 Small islets have been shown to secret more insulin than large islets when normalized to 
tissue volume (islet equivalent; IE) (H.-H. Huang et al., 2011; Lehmann et al., 2007; MacGregor 
et al., 2006; Su et al., 2010; Williams et al., 2010; Yasutaka Fujita, 2011) and led to better 
transplantation outcome both in rodents (MacGregor et al., 2006; Su et al., 2010) and in human 
(Lehmann et al., 2007). However, the detailed mechanisms of insulin production and secretion in 
different sized islets are unclear. Previously, our group suggested that diffusion barrier in 
isolated large islets may hamper the islet function. Surprisingly, elimination of diffusion barrier 
in large islets improved the survival, but failed to improve the inferior in vitro insulin secretion 
to the same rate as intact small islets, indicating that there might be an inherent cellular 
difference in insulin production or secretion capacity between small and large islets (Williams et 
al., 2010).  
 The objective of present work was to determine whether the insulin producing 
mechanisms are different between the β cells in small and large islets. We investigated the 
insulin biosynthesis and secretion during the early response to glucose stimulation in small and 
large isolated rat islets, with the goal of elucidating new intricacies concerning cell biology 
according to the size differences of islets.  
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4.3. Methods 
Rat islet isolation and separation 
Adult male Sprague Dawley rats (200~250g BW) were housed on a 12 hours light/dark 
cycle with free access to standard laboratory chow and water. All animals received care in 
compliance with the Principles of Laboratory Animal Care formulated by the National Society 
for Medical Research and the Guide for the Care and Use of Laboratory Animals published by 
the US National Institutes of Health (NIH Publication No. 85-23, revised 1996). 
Islet isolation methods followed our published procedures described in detail (H.-H. Huang 
et al., 2011; MacGregor et al., 2006; Williams et al., 2010; S. Williams et al., 2009). Briefly, rats 
were anesthetized by intraperitoneal injection of a mixture of ketamine and xylazine. After the 
peritoneal cavity was exposed, the pancreatic main duct to the intestine was clamped and the 
pancreas cannulated in situ via the common bile duct. The pancreas was distended with 
collagenase and removed. Islets were gently tumbled, washed, and passed through a sterile 30 
mesh stainless steel screen and centrifuged. The pellet was mixed with Histopaque, centrifuged, 
and the islets floating on the gradient were collected and sedimented. Islets were passed through 
a sterile 40µm mesh cell strainer with HBSS. After this cleaning process, islets were placed into 
CMRL1066 medium containing 2 mM glutamine, 10% fetal bovine serum (FBS) and 1% 
antibiotic/ antimycotic solution and put into a 37ºC culture chamber containing 5% CO2. 
For large and small islet separation, the islet culture media was changed to L15 containing 
10% FBS and 5mM HEPES, and islets were transferred into 37ºC culture chamber without CO2. 
Isolated islets were manually separated by size based on the criteria that small: diameter ≤ 
100µm; large: diameter ≥ 200µm. Finally, the total cell numbers in the selected small or large 
islets being used in each experiment were estimated based on our model in Chapter 3.  
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Islet perifusion 
Approximately 850 small islets and 120 large islets were used individually in each set of 
perifusion experiment. First, small and large islets were preincubated for 90 minutes in RPMI 
1640 medium containing 10% FBS and 3mM glucose at a 37°C with 5% CO2. After 
preincubation, the islets were incubated in the glucose perifusion system individually with a 
constant flow rate (500 µl/min) at 37°C for 90 minutes including: 30 minutes of basal condition 
(3mM glucose) following by 30 minutes of high glucose concentration (20mM) and 30 minutes 
of basal condition (3mM glucose). During the perifusion, samples of medium with released 
insulin were collected from the output fraction every 3 minutes starting with the last 10 minutes 
of the first low glucose exposure. Samples were frozen at -80°C. At the end of the perifusion, the 
islets were harvested and frozen at -80°C. The total insulin content in the islets was extracted by 
acid ethanol (0.18 M HCl in 95% ethanol). The released insulin and the total islet insulin content 
were determined by the ELISA kit (ALPCO, Salem, NH, USA) as we have published previously 
(H.-H. Huang et al., 2011; MacGregor et al., 2006; Williams et al., 2010). The stimulation index 
was calculated as the ratio of averaged insulin released amount per 100 cells under high glucose 
over averaged insulin released under low glucose (basal condition) (Clayton, Turner, Swift, 
James, & Bell, 2001; Coffey, Berman, Willman, & Kenyon, 2009; Robitaille, Dusseault, Henley, 
Rosenberg, & Halle, 2003).  
Islet static incubation  
 Islet static incubation assays followed our published procedures (H.-H. Huang et al., 2011; 
MacGregor et al., 2006; Williams et al., 2010). Isolated islets were placed in 24-well plates with 
a minimum of 5 large or 15 small islets per well. All wells were preincubated for 2.5 hours in 
RPMI 1640 containing 10% fetal bovine serum and 3 mM glucose in a 37°C containing 5% CO2. 
After preincubation, media was removed from each well and discarded. Low (3 mM as basal 
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condition) or high (16.6 mM) glucose solutions were added, according to the design. After a 30 
minutes static incubation at 37°C and 5% CO2, the islets were harvested and frozen at -80°C. 
The total protein in the islets was extracted by sonication in acid ethanol (0.18M HCl in 95% 
ethanol) and incubated overnight at 4°C. The total intracellular proinsulin and insulin amounts in 
the extracts were determined separately by the ELISA (ALPCO, Salem, NH, USA). 
Western Blot 
 After 30 minutes low or high glucose static incubation, the small and large islets were 
harvested and washed in phosphate-buffered saline (PBS) twice. After removing the supernatant, 
the large and small islets were homogenized using a 26G1/2 syringe with extraction buffer 
containing 10mM TRIS HCl pH7.4, 150mM NaCl, 1mM EDTA, 20mM Na Molybolate, 50mM 
Na Fluoride, 0.2mM Na-Orthovanidate (pH 10), 1% Triton X-100, and 0.2mM PMSF. The 
extracts were centrifuged for 15 minutes with 15,600 rcf at 4°C. Measurement of protein 
concentrations in supernatants was performed using Micro BCA Protein Assay Kit (Pierce, 
Rockford, IL, U.S.A., #23235). The protein samples from large and small islets extracts were 
prepared for electrophoresis by heating at 95 oC for 3 min in SDS gel-loading buffer (0.125M 
Tris, pH6.8, 5% glycerol, 2.5% mercaptoethanol, 2% SDS, and 0,001% bromophenol blue). 
Proteins were separated on a 4-15% Tris-HCl Ready Gels (Bio-Rad Laboratories, Hercules, CA, 
U.S.A., #161-1158) with 0.025 M Tris, 0.192 M Glycine, 0.1% SDS running buffer. Equal 
amounts of total protein (10 µg) were loaded in each lane. Molecular weight markers See Blue 
Plus2 Pre-Stained Standard (Invitrogen, Carlsbad, CA, U.S.A., #LC5925) were used to 
determine the size of the antigen. After electrophoresis, the proteins were transferred from the 
gel to Bio Trace PVDF membranes 0.45 µm (Pall Life Sciences, East Hills, NY, U.S.A., #P/N 
66547) using 0.012 M Tris, 0.096 M Glycine transfer buffer. Blots were blocked with 5% nonfat 
dry milk diluted in 0.1M PBS 0.1% Tween (PBST) for 1 hour. Primary antibodies were diluted 
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in the 5% nonfat dry milk or 5% BSA in PBST according to the manufacturer's directions. Blots 
were probed with primary antibodies against Glut2 (Santa Cruz Biotechnology Inc., Santa Cruz, 
CA, U.S.A., #sc-9917), MafA (Santa Cruz Biotechnology Inc., Santa Cruz, CA, U.S.A., 
#sc-66958), PDX-1 (Cell Signaling Technology Inc. Danvers, MA, U.S.A., #2437), NeuroD 
(Cell Signaling Technology Inc. Danvers, MA, U.S.A., #4373) and incubated at room 
temperature for 1 hour or at 4°C overnight according to the manufacturer's directions. After 
washing in 0.1M PBS 0.1% Tween (10 minutes for 3 times), blots were incubated for 30 minutes 
with secondary antibody horseradish peroxidase-conjugated goat anti-rabbit IgG (Santa Cruz 
Biotechnology Inc., Santa Cruz, CA, U.S.A., #sc-2004) or goat anti-mouse IgG (Santa Cruz 
Biotechnology Inc., Santa Cruz, CA, U.S.A., #sc-2005). After washing in 0.1M PBS 0.1% 
Tween (10 minutes, 3 times), bound antibodies were detected using SuperSignal® West Pico 
Chemiluminescent Substrate (Thermo Fisher Scientific Inc., Rockford, IL, U.S.A., # 34080). For 
a protein loading control, the membrane was reprobed with mouse anti GAPDH 
(Sigma-Aldrich®, St. Louis, MO, U.S.A., #G8795), for 1 hour at room temperature.  
RT-qPCR 
 Total RNA was isolated from islets using RNeasy Mini kit (Qiagene) according to the 
manufacturer’s instructions and quantified by spectroscopy. An equal quantity of total RNA (500 
ng) from each subject was reverse transcribed into cDNA using TaqMan® Reverse Transcription 
Reagents (Applied Biosystems, Chicago, IL, U.S.A., #N8080234) according to the 
manufacturer’s instructions. For real-time PRC, 150ng cDNA products were mixed in TaqMan® 
Gene Expression Master Mix (Applied Biosystems, Chicago, IL, U.S.A., #4369106) together 
with gene specific primers: Insulin 1, Insulin 2, PDX1, MafA, NeourD (Applied Biosystems, 
Chicago, IL, U.S.A., #4448892) and GAPDH (Applied Biosystems, Chicago, IL, U.S.A., 
#4331182). Real-time PCR was carried out in an ABI Prism 7000® Sequence Detection System 
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(Applied Biosystems, Chicago, IL, U.S.A.). The amount of transcript was calculated using the 
comparative cycle threshold (CT) method, which determines the amount of target genes against 
GAPDH as the normalization gene. Normalized CT values were averaged to produce the mean CT 
value for each gene analyzed. 
Statistics 
 The experimental design included comparing islets from healthy animals, thus each 
animal provided both large and small islets for the comparison studies (low and high glucose). 
The exact number of islets used in each experiment is shown in each figure legend. Results were 
expressed as mean of each group or islet population ± SEM. Where appropriate, differences 
between groups were examined for significance using one- or two-way ANOVA (factors: islet 
size and glucose concentration) followed by the Fisher’s least significant difference (LSD) post 
hoc test. Unpaired Student’s t-test was used for the comparisons between small and large islets 
under basal conditions. Significant differences were defined as p < 0.05.
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4.4. Results 
Glucose transporter (Glut2) 
 Glucose entry into the β cell is accomplished via the Glut2 located on the plasma 
membrane and activates insulin gene transcription, translation, and secretion through a complex 
network of intracellular signaling pathways described previously. The protein levels of Glut2 
were determined by Western Blot. After 30 minutes of high glucose, Glut2 levels did not change 
significantly. In addition, Glut2 was not significantly different between small and large islets 
(Figure 20).  
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Figure 20. Glucose transporter (Glut2) protein levels. There were no differences in Glut2 
levels between small and large islets, under basal conditions (3mM glucose) or after 30 minutes 
high (16.6mM) glucose stimulation. N = 5 experiments in each group. Each experiment 
contained at least 3,000 small islets or 600 large islets from 6 rats. The expressions in each group 
were presented as relative fold difference to small islets under low glucose.  
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Glucose-stimulated Insulin Gene Transcription 
 In rat islets, there are two insulin genes, insulin 1 and insulin 2, which are transcribed into 
two preproinsulin mRNAs, insulin 1 mRNA and insulin 2 mRNA. After 30 minutes of high 
glucose, the mRNA levels of insulin 1 and insulin 2 in either small or large islets did not increase 
significantly. Under basal conditions, the mRNA expressions of both the insulin 1 and insulin 2 
tended to be higher in large islets but not statistically significant (Figure 21A & B).  
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Figure 21. Preproinsulin mRNA levels. There are two insulin genes, insulin1 (A) and insulin2 
(B), in rat islets. After 30 minutes glucose stimulation, the mRNA levels of insulin 1 and insulin 
2 in either small or large islets did not increase significantly. N = 3 experiments in each group. 
Each experiment contained at least 3,000 small islets or 600 large islets from 6 rats. The 
expressions in each group were presented as relative fold difference to small islets under low 
glucose.  
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 The gene expressions of three transcription factors (MafA, NeuroD/Beta2 and PDX-1) 
involved in the upregulation of insulin gene expression were assayed at both the mRNA and 
protein levels. After 30 minutes of high glucose, the gene expressions of MafA and 
NeuroD/Beta2 in both mRNA and protein levels did not significantly change in either population 
of islets (Figure 22A toD). The PDX-1 protein levels decreased significantly in both small and 
large islets after 30 minutes high glucose stimulation (Figure 22F). However, the decreases were 
not seen in the mRNA levels (Figure 22E). 
 After reanalyzing the data from the low glucose group by using unpaired t-test, the gene 
expressions of MafA and NeuroD/Beta2 in both mRNA and protein levels were showing 
significantly higher in large islets under basal conditions (Figure 22A toD). However, the PDX-1 
protein levels were significantly lower in large islets, but the decrease was not seen in the mRNA 
levels (Figure 22E and F).  
Glucose-stimulated Insulin Gene Translation 
 After 30 minutes high glucose stimulation, proinsulin levels increased significantly in 
both the small and large islets. Furthermore, in high glucose condition, the large islets had more 
proinsulin, when normalized to cell numbers, than small islets (Figure 23A). When measuring 
the downstream product, insulin, there was not a significant glucose-stimulated increase in 
insulin content in either the large or small islets (Figure 23B). After reanalyzing the data from 
the low glucose group by using unpaired t-test, proinsulin levels were significantly higher in the 
large islets (Figure 23A). However, there was no difference in insulin content between small and 
large islets, when normalized to cell number (Figure 23B). 
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Figure 22. Gene expressions of insulin gene transcription factors. (A) MafA mRNA levels; 
(B) MafA protein levels; (C) NeuroD/Beta2 mRNA levels; (D) NeuroD/Beta2 protein levels; (E) 
PDX-1 mRNA levels; (F) PDX-1 protein levels. MafA and NeuroD/Beta2 in both mRNA and 
protein levels did not significantly change after 30 minutes high glucose in either small or large 
islets, but PDX-1 protein levels decreased significantly in both small and large islets. After 
reanalyzing the data by using unpaired t-test, MafA and NeuroD/Beta2 in both mRNA and 
protein levels showed significantly higher levels in large islets under basal conditions. However, 
the PDX-1 protein levels were significantly lower in large islets. N = 3 experiments in each 
group. Each experiment contained at least 3,000 small islets or 600 large islets from 6 rats. The 
expressions in each group were presented as relative fold difference to small islets under low 
glucose. (#: p < 0.05 according to two-way ANOVA with Fisher’s LSD test; *: p < 0.05 
according to unparied t-test) 
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Figure 23. Proinsulin and insulin content per cell. (A) When normalized to cell, total 
proinsulin content from small and large isolated islets (measured by ELISA) showed that large 
islets contained more proinsulin per cell in high glucose. In addition, both small and large islets 
contained higher proisnulin levels in high glucose when compared to basal conditions. Large 
islets contained more proinsulin per cell under basal conditions when compared using t-test. (B) 
When normalized to cell, total insulin content showed no significant difference in both small and 
large islet under basal conditions or high glucose. N = 6 experiments in each group. Each 
experiment contained at least 40 small islets or 10 large islets from 2 rats. (#: p < 0.05 according 
to two-way ANOVA with Fisher’s LSD test; *: p < 0.05 according to unparied t-test) 
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Glucose-stimulated Insulin Secretion 
 Figure 24A illustrated the results of insulin secretion in the glucose perifusion 
experiments. Under high glucose stimulation, the typical biphasic responses (between 0 and 20 
minute) were recognized in both small and large islets indicating that both islet populations had 
normal glucose-stimulated secretion patterns (Figure 24A). When normalized to cell number, 
there was no statistical difference in the level of the insulin secretion between small and large 
islets. At the end of experiment, the total insulin content per cell was no different between small 
and large islets (0.12 ± 0.02 vs. 0.11 ± 0.02 ng per cell, p = 0.74) under basal conditions. While 
there were some time-dependent differences in the responses between the two groups, the 
calculated area under curve showed no difference (p = 0.98) between two groups which indicated 
that the total amount of secreted insulin over the experiments was not different in small and large 
islets (Figure 24B). Interestingly, the stimulation index (SI), which calculates the percent 
increase in insulin secretion compared to basal rates, was higher in the large islets than in smalls 
(3.16 ± 0.40 vs. 1.95 ± 0.31, p < 0.05) indicating that large islets might have higher 
responsiveness to glucose for insulin secretion. 
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Figure 24. Glucose-stimulated insulin secretion. (A) When normalized to cell, there was no 
statistical difference in the level or timing of the insulin secretion rate between small and large 
islets except at 30 and 36 minutes. (B) The area under the curve (between 0 to 45 minute) was 
not different between small and large islets (p = 0.98). N = 3 experiments in each group. Each 
experiment contained at least 850 small islets or 120 large islets from 2 rats. (*: p < 0.05 
according to two-way ANOVA with Fisher’s LSD test) 
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4.5. Discussion 
  Our group has been engaged in determining whether small and large islets have different 
mechanisms in the insulin production that lead to inferior insulin secretion per volume (islet 
equivalent, IE) in large islets. We hypothesized that the diffusion barrier in large islets may play 
a role. However, elimination of the diffusion in the large islets improved the viability but did not 
improve the insulin secretion, which indicated diffusion barrier can not account for the inferior 
insulin secretion per IE in large islets (Williams et al., 2010). Next, we questioned the accuracy 
of using IE as a normalization method. We identified an overestimation in tissue volume 
quantification when using IE, which may underestimate the actual islet function especially in 
large islets. In addition, islet tissue is cluster of cells and there was no difference in the 
percentage of insulin-producing β cells between small and large islet in vitro or in situ (H. H. 
Huang et al., 2011). Therefore, at present work, we used total cell number in islets to normalize 
insulin secretion between groups. Surprisingly, when normalized to cell number, there was no 
difference in insulin secretion between small and large islets. Therefore, we suggested the 
previous conclusion of different insulin secretion between small and large islets when 
normalized by IE needs to be reconsidered.  
 Glucose is the main regulator of insulin biosynthesis including insulin gene transcription 
and translation in β cell. It was commonly believed that over a short period, glucose regulates the 
insulin biosynthesis mainly by increasing the translation of preproinsulin mRNA rather than 
insulin gene transcription. The effect of glucose in insulin gene transcription was commonly 
accepted as a long-term effect. Thus, the previous reports for the mechanisms of 
glucose-stimulated insulin gene transcription were mainly designed in the high glucose static 
incubation over several hours or even days (Khoo et al., 2003; Ling, Heimberg, Foriers, Schuit, 
& Pipeleers, 1998; Ritz-Laser et al., 1999). However, there were two groups reporting that a 
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short time period of glucose stimulation elevated the preproinsulin mRNA levels in β cells. Efrat 
et al. suggested that 10 minutes high glucose (16.7 mM) stimulates insulin gene transcription 
about 3-fold, and the transcriptional activity is maximal at 30 minutes (Efrat et al., 1991). In 
addition, Leibiger et al. reported that incubating isolated rat islets in high glucose (16.7 mM) for 
only 15 minutes, results in a 5-fold elevation in preproinsulin mRNA levels within 60 minutes 
after stimulation (Leibiger et al., 1998). Moreover, from the physiological perspective, β cells in 
the pancreatic islets are exposed to the elevated glucose for minutes after food-uptake. Therefore, 
we chose 30 minutes high glucose stimulation to investigate the mechanisms of insulin gene 
transcription and translation. The results showed that both small and large showed a significant 
increase in proinsulin content, the product after preproinsulin mRNA translation, after 30 
minutes high glucose challenge. This result was in agreement with the well-accepted argument 
described above. However, in insulin gene transcription, there was no significant increase in 
preproinsulin mRNA between basal conditions and 30 minutes high glucose stimulation in both 
groups of islets. The different experimental design could explain the inconsistency between my 
results and the previous reports by Efrat and Leibiger. First, Efrat et al. used β tumor cell lines 
and here, we used isolated rat islets here. Second, Leibiger et al. extracted the RNA from isolated 
rat islets 60 minutes after the start of 15 minutes high glucose stimulation. Whereas, we extracted 
the RNA from islets right after the 30 minute glucose stimulation. Therefore, we suggest that 
how acute glucose stimulation affects insulin gene transcription remains unclear.  
In addition, we determined whether insulin gene transcription factors play role in early 
phase of glucose-stimulated insulin biosynthesis. After 30 minutes of high glucose, there were no 
significant changes in the gene expressions of MafA and NeuroD/Beta2 compared to the basal 
conditions. Interestingly, 30 minutes of high glucose stimulation significantly decreased the 
PDX-1 protein levels in both groups of islets. However, one study using MIN6 cells (β cell line) 
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showed that PDX-1 protein levels were increased after 30 minutes high glucose 
(16mM)(Macfarlane et al., 1999). Another study showed an increased PDX-1 gene expression in 
mRNA levels in rat islets after one hour high glucose (16mM) stimulation (Vilches-Flores, 
Delgado-Buenrostro, Navarrete-Vazquez, & Villalobos-Molina, 2010). To our best 
understanding, our finding is the first showing that acute glucose stimulation suppressed PDX-1 
protein levels in isolated rat islets. Therefore, we suggested the detailed mechanisms about how 
PDX-1 gene expressions are regulated in early phase of glucose-stimulated insulin gene 
transcription remains to be elucidated.    
  After 30 minutes of high glucose stimulation, there was higher proinsulin biosynthesis in 
large islets. However, the difference was not seen in the downstream product, insulin content. 
The reason might be due to the relative fold difference is huge between insulin and proinsulin in 
the cell. On average, the proinsulin content is approximately 0.43~1.85 pg per cell while the 
insulin content is approximately 99~138 pg per cell, which is about 110 times higher than 
proinsulin. Therefore, the changes in insulin levels in early response to glucose might not be 
identified as significantly as the proinsulin. In addition, it has been suggested that insulin content 
was not associated with the insulin secretory capacity (Uchizono, Alarcon, Wicksteed, Marsh, & 
Rhodes, 2007). The reason might be due to the large in the intracellular insulin storage pool in 
comparison to the releasable pool (Rorsman & Renstrom, 2003). Moreover, it has been also 
suggested that young newly formed insulin granules are preferentially secreted (Howell & 
Taylor, 1967; Rhodes & Halban, 1987) while the majority of stored insulin granules are old, and 
if they do not undergo exocytosis, are retired by intracellular degradation with a 3 to 5 days 
half-life (Halban, 1991; Halban & Wollheim, 1980; Schnell, Swenne, & Borg, 1988). In our 
perifusion study, the total amount of insulin secreted under high glucose stimulation was only 
less than 0.05% of total insulin content in both small and large islets. Therefore, it seems likely 
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that the superior proinsulin biosynthesis in large islets did not correspond to insulin secretion in 
early response to glucose, and therefore is not a good predictor of functional islet secretion.  
 In chapter 3, we reported that there was no significant difference in total protein per cell 
between small and large islets. Similar results were also found when normalized by total DNA. 
In this chapter, after reanalyzing the protein levels in small and large islets under basal 
conditions by using t-test, higher MafA and Beta2/NeuroD protein levels were seen in large 
islets. The same trends were also shown in mRNA levels. In addition, PDX-1 protein levels were 
lower in large islets. All these findings implied that small and large islets may possess some 
inherent differences in gene expressions of these transcription factors. 
 In summary, the difference in the mechanisms of insulin gene transcription between 
small and large islets can not be concluded when the islets were challenged by 30 minutes of 
high glucose stimulation. However, we identified a higher glucose-stimulated proinsulin content 
in large islets, while there was no significant difference in insulin content and secretion between 
small and large islets when normalized by cell. These findings implied that the superior 
glucose-stimulated proinsulin biosynthesis in large islets may not correspond to insulin secretion 
in early phase of glucose stimulation. 
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5.1. Summary of findings 
 Solid understanding for islet biology is believed to be crucial to optimize the success of 
curing diabetes. However, the previous conclusions in the literature about isolated islets have 
been based on the conventional IE measurement for tissue volume normalization, and may need 
to be reconsidered. In this dissertation, I have proven that the IE measurement overestimated the 
tissue amount being used, leading to some erroneous conclusions being drawn from the 
experiments. Accordingly, I proposed a more accurate method to normalize islet tissue volume 
by using the total cell number. Based on this new measurement, the different characteristics in 
the insulin production and secretion pathway between small and large islets were identified. 
 Compared to small islets, large islets have superior glucose-stimulated proinsulin 
biosynthesis after 30 minutes glucose stimulation. However, no significant changes could be 
identified at the transcriptional levels except the decrease in PDX-1, even though this short time 
period of high glucose mimics a physiological-like challenge in vivo. Surprisingly, when 
normalized to cell number, insulin secretion was not different between small and large islets, 
unlike the results published previously in the literatures when normalized to IE. In addition, 
small and large islets have the same percentage of β cells, but small islets have higher density 
both in vitro and in situ. While small and large islets might contain the same amount of protein 
per cell, large islets showed higher protein levels of prosinulin, NeuroD/Beta2 and MafA with a 
lower PDX-1 under basal conditions. Therefore, it seems like that the different characteristics 
between small and large islets in the insulin production pathway did not correspond to measured 
insulin secretion. 
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5.2. Discussion  
5.2.1. The implications to islet transplantation  
 A consistent and accurate method to quantify the yield of isolated islet is of critical 
importance to the transplantation in the clinic. The findings in this dissertation may have direct 
and significant implications to current islets transplantation. To date, islet transplantation is an 
experimental procedure for type 1 diabetic patients. From 1999 to 2008, approximately 828 islet 
transplantation perfusions have been performed on 412 patients in more than 40 institutions 
worldwide (Alejandro, Barton, Hering, & Wease, 2008). By placing healthy insulin-producing 
islets into the recipients, the islet transplantation procedure is capable of producing a stable blood 
glucose level, especially reducing the incidence of hypoglycemia for severely ill patients with 
type 1 diabetes. However, the outcome of normal glycemic control for diabetics has only been a 
clinical reality for a short period of time.  
 In the clinic, IE is highly relied on to quantify the dosage of the islets transplanted. 
However, in this dissertation, one of my conclusions was that IE is not an accurate measurement 
for islet volume. Thus, all the previous reports about islet tissue yield from the donors and the 
dosage of transplantation for the recipients may need to be reconsidered. I believe the inaccuracy 
in the tissue volume estimation might be directly or indirectly related to the transplantation 
outcome. Therefore, it will be very significant to perform another retrospective study on the 
correlation between the transplantation outcome and the actual tissue volume received by the 
patients by recalculating the previous data of islet volume from IE to total cell number. It is my 
expectation that the total cell number being transplanted will be a more reliable and valid 
predictor for islet transplantation outcome.     
 Transplanting small islets has been suggested as having a better outcome in humans 
(Lehmann et al., 2007) and in rodents (MacGregor et al., 2006; Su et al., 2010). One of the 
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assumptions was that the better transplantation outcome was due to greater insulin secretion in 
small islets. Here, I showed small and large islets have the same insulin secretion rate no matter 
when normalized to cell or normalized to total insulin content. Therefore, these results basically 
have ruled out this assumption. While there are some other factors that may affect the results of 
transplantation such as the quality of islet graft after isolation (Lakey, Tsujimura, Shapiro, & 
Kuroda, 2002; Lakey et al., 1996; Ricordi et al., 2003; R. M. Smith & Gale, 2005) and the 
revascularization rate of islets after transplantation (Menger et al., 1989), our research group 
suggested the superior transplantation outcome when using small islets might be mainly due to 
diffusion barriers in large islets. In the pancreas, islets are nourished by adequate blood supply 
(Ballian & Brunicardi, 2007; Zanone et al., 2008). Whereas, in culture or after transplantation, 
the nutrition and oxygen supply solely rely on diffusion. The long diffusion distance in large 
islets has been shown related to poor cell viability with a more dead cells in the core area 
(Lehmann et al., 2007; MacGregor et al., 2006; Williams et al., 2010; S. J. Williams et al., 2009). 
Even though small and large islets have same insulin secreting rate, I suggest that the potency 
small islets with their greater viability cannot be overlooked for transplantation. 
 When normalizing total cell number in one islet to its relative IE value, I identified an 
inverse correlation between total cell number per IE and islet size, which indicated that more 
cells per IE in small islets than in large islets. Since the two reports in rodents described above 
(MacGregor et al., 2006; Su et al., 2010) were transplanting same IE of small and large islets in 
to diabetic animals, there might be a possibility that the better outcome in small islets was due to 
more islet cells were transplanted. However, without further reanalyzing the original data of IE 
measurement by using our new method, this assumption could not be tested. Therefore, it will be 
a very significant future study to transplant the same number of cells from small or large islets 
into the diabetic animals and compare the results.  
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5.2.2. The implications to islet biology research 
 The findings of different characteristics existing in small and large islets strengthened the 
justification for normalizing islet tissue amount being used when comparing results between 
preparations in islet research. In early days, normalizing to islet number was one of the common 
methods. Yet, islet size has been suggested a major determinant for functional heterogeneity 
among islets (Reaven, Gold, Walker, & Reaven, 1981). For example, when compared 
side-by-side, one large islet can produce more insulin than one small islet (T. Aizawa et al., 
2001). Thus, the variability between different sizes of islets in each preparation must be 
considered in the experiments. In other words, the results might not be correct, if the data were 
simply normalized to islet number. Therefore, to avoid the variability due to islet size, several 
other normalization methods including islet dry weight (Wolters & Konijnendijk, 1980), total 
protein content (Hayek & Woodside, 1979), insulin content (Schatz, Maier, Hinz, Nierle, & 
Pfeiffer, 1973), total DNA content (Colella, Bonner-Weir, Braunstein, Schwalke, & Weir, 1985), 
islet area seen under the stereomicroscope (Jahr, Gottschling, & Zuhlke, 1978) and islet volume 
(Hayek & Woodside, 1979; Reaven et al., 1981) have been used in the literature. Among all, 
normalizing to islet volume is suggested as the simpler and more convenient method (Reaven et 
al., 1981). As I described previously, IE currently is a popular measurement based on the concept 
of islet volume for the islet research for transplantation in laboratories. However, I showed IE is 
not accurate to estimate islet volume. Therefore, I suggested total cell number is the best estimate 
for islet volume. To our best understanding, the only other group that also suggesting this 
method is Pisania et al.. They also concluded normalizing to total cell number can avoid the 
overestimation when using IE measurement (Pisania, Weir et al., 2010). Therefore, I suggested 
that the functional heterogeneity between various sizes of islets must be considered and 
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normalizing islet volume by total cell number is highly recommended when comparing the 
results of each preparation in the islet biology researches.  
  One may raise the questions about the relationship between small and large islets and 
whether these two populations play different roles in glucose homeostasis in the pancreas. One 
of the assumptions is that large islets might be born from small islets to functionally compensate 
the metabolic demand in body. It has been suggested that the β cells in adult pancreatic islets 
exhibited a plasticity in increasing their population to adapt natural changes in metabolic load 
such as obesity or pregnancy (Bouwens & Rooman, 2005; Dhawan, Georgia, & Bhushan, 2007). 
In our lab, we have seen cell proliferation (both in α and β cells) in 100% of large islets, but only 
in 42% of small islets in the rat pancreas (data not shown). In addition, it has been shown that 
there are more small islets in the pancreas, even though the small islets accounted for only a very 
small percentage of the total islet volume (Hellman, 1959a; Kaihoh et al., 1986; MacGregor et 
al., 2006). Therefore, it seems likely that most small islets in the pancreas were silent until they 
are triggered to proliferate by some external stimuli when necessary. Small islets may hold the 
capacity to become large islets to compensate the body demand. Thus, large islets may take 
more responsibility of glucose homeostasis if they developed because of the extra body demand. 
The higher stimulation index in large islets I have shown here, which is in agreement with a 
previous report (T Aizawa et al., 2001), might be able to support this argument. In addition, 
under low glucose conditions (static incubation), small islets secreted more insulin per cell than 
large islets (data not shown). Whereas, when facing high glucose, we have seen insulin secretion 
in large islets was comparable to small islets when normalized to cell. Therefore, I suggested 
large islets might develop from small islets to compensate for metabolic demand, while small 
islets are the main insulin secretors under basal conditions. Although the hypothesis maybe over 
simplistic, it is based on my insulin secretion results, a common method to study islets.  
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5.2.3. Inconsistent results in insulin content in vitro and in situ 
 There was an inconsistency in the results of insulin content between chapter 2 and 
chapter 4. In chapter 2, large islets showed a lower insulin content in vitro and in situ. However, 
in chapter 4, there was no difference in insulin content between small and large islets when 
normalized by cell in vitro. There are at least four possibilities that can account for this conflict.  
 First, the techniques used and normalization methods were different. In chapter 2, two 
different methods were used to measure the insulin content in vitro. The first approach was to 
detect the insulin levels from the protein extract of whole islet tissue by ELISA and normalized 
the results by IE. However, as I suggested, the method of data normalization may affected the in 
vitro results. Therefore, I believe the results in chapter 4 could be more representative to the truth. 
The second method was using the TEM histological approach to estimate the number of insulin 
granules per β cell area on the tissue section of isolated islets. The result showed that β cell from 
isolated large islets had less insulin granules per area of cell. There are certainly inherent 
limitations in image analysis when applying two-dimensional histological techniques to study the 
three-dimensional isolated islet. In other words, the insulin granules density measured under a 
two-dimensional plane may not be representative enough to the total amount of insulin granules 
in a three-dimensional islet. Therefore, increasing the sample size being measured on the serial 
sections of the same cell and average the data might be able to minimize this limitation. 
 Second, the isolation procedure removes islets from the surrounding exocrine tissue using 
an enzymatic process. It is well known that the isolation process is more detrimental to some 
cells compared to others. Potentially, this process could change the insulin content of islets 
(Brandhorst, Brandhorst, Brendel, Hering, & Bretzel, 1998) and especially affect cells at the 
periphery (el-Naggar et al., 1993; Morini et al., 2006). Therefore, in vivo islets have a different 
level than in vitro. One assumption is that higher surface area per volume in small islets may 
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have greater chance in losing insulin granules at the periphery of islets than the large islets 
during the isolation process. To avoid the limitation due to isolation procedure, laser capture 
microdissection (LCM) technique can be applied to harvest the islets directly from the pancreas. 
Therefore, the insulin content from the LCM-collected islets could be measured and compared to 
the isolated islets.   
 Third, there may not be a correlation between in the number of insulin granules and the 
total insulin content. In addition, the variability due to the size of the granules also needs to be 
considered. Therefore, to test this assumption, it will be significant to re-estimate the granule 
density by measuring the ratio of total area of insulin granules to total β cell area and analysis the 
correlation with total insulin content in small and large islets.  
 Last but not least, the results of insulin content per cell in chapter 4 might be 
underestimated, because the data were normalized by total islet cells including β cells and non-β 
cells. To examine this hypothesis, the β cells from small or large isolated islets could be sorted 
out by flow cytometer after dissociating the islets into single cells and measured for the insulin 
content after homogenizing the cells.  
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5.3. Future Directions 
5.3.1. Estimating islet volume by cell number in humans 
 I have created and tested a new method to better estimate islet volume by cell number in 
rat. It is of crucial to apply the same concept and techniques to establish a new model in human 
islets. In addition, I will consider the variations of islets from donors between age, gender, body 
weight, and race etc. I believe all the efforts will have a direct and immediate implication on 
human islet research and transplantation. 
5.3.2. Performing retrospective studies for transplantation outcome 
 Our lab will cooperate with human islet transplantation institutes to perform a series of 
retrospective studies. We will reanalyze the dosage of islets that patients received based on our 
cell number model and investigate the correlation between the transplantation outcome and the 
actual tissue volume received by the patients. 
5.3.3. Transplant same amount of cells from small and large islets 
 To better understand how the characteristic differences between small and large islets 
affect transplantation outcomes, it will be necessary to transplant islets based on an accurate 
standardization of the tissue amount. Therefore, it will be a very significant to transplant the 
same amount of cells from small or large islets into diabetic animals and compare the results.  
5.3.4. Integrating our volume estimation model with the digital image analysis method 
 It has been suggested that the digital image analysis (DIA) method offers the advantages 
of minimizing operator-dependant variations and shortening the evaluation time when estimating 
the volume of islets especially with low purity or irregular shapes (Friberg et al., 2011). The 
typical procedure utilizing the DIA method estimates the islet size by computer and calculates 
the IE accordingly. The new method I proposed here is based on the standard clinical procedure 
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to measure the islet size manually under the microscope. Thus, a future approach will be to blend 
my cell number procedure with the DIA method. In other words, another new regression model 
could be established based on total cell number per islet and the islet size measured by the DIA 
method. Therefore, my goal is to create a patentable computer system with a solid data base 
according to different categories of tissue source as described above, and distribute the system to 
ensure the most accurate estimation on islet tissue volume will always be used in islet research 
and transplantation.  
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5.4. Overall Summary 
This dissertation is innovative because it is the first investigation of insulin production and 
secretion properties between islet subpopulations at the cellular and molecular level. We have 
obtained greater understanding of the biological foundation of islets as well as a better method to 
quantify islets for research and clinical use. It is my expectation that all the efforts will not only 
elucidate new intricacies concerning islet biology that will guide other researchers working in 
related fields such as converting stem cells to insulin-producing β cells or regenerating β cells, 
but also will have a significant positive impact on the current islet transplantation research to 
optimize the success for curing type 1 diabetes. 
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